y4565z‚»[‚¹‚¢G 45 ..
[2ch|¥Menu]
423:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 17:31:18.68 r9lyFCZD0.net
¦ƒƒ‹ƒgƒŒF‚»[‚¹‚¢ƒOƒ‹[ƒvHTL18318‚Ì‘“àƒtƒF[ƒY2ŽŽŒ±‚ª8ŒŽ‚ÉŠJŽnBuHTL18318 ƒZ[ƒ‹ƒXƒs[ƒN800‰­‰~—\‘zvB‘“à‘åŽèØŒ”ƒoƒCƒIƒZƒNƒ^[ƒAƒiƒŠƒXƒg‚ÍAud—v‚Èi’»‚Ńvƒ‰ƒX‚ȈóÛv‚ƃRƒƒ“ƒgB¡‰ñ‚ÌŽŽŒ±ŠúŠÔ‚Í2018”N8ŒŽ`2021”N1ŒŽ‚Ì—\’èAŠ³ŽÒ”172lA—LŒø«‚ÌŠÏŽ@ŠúŠÔ‚Í12TŠÔB(7/25)
¦‚¢‚¸‚Ý‚Ì•a‰@(‘n–òƒZƒ“ƒ^[‚¢‚¸‚Ý‚Ì)‘æ103‰ñŽ¡Œ±R¸ˆÏˆõ‰ïFyR¸Ž–€zŽ¡Œ±(‚»[‚¹‚¢ˆË—Š‚É‚æ‚郌ƒr[¬‘ÌŒ^”F’mÇŠ³ŽÒ‘ÎÛ HTL0018318ŽŽŒ±)‚ÌŽÀŽ{‚Ì“K”ۂɂ‚¢‚ÄFyR¸Œ‹‰ÊzF—¹³B(7/25)
¦Heptares: "All set for our study of HTL0018318 in Patients with Dementia with Lewy Bodies (DLB)": ClinicalTrials(NCT03592862: HTL0018318-203) (7/25)
¦AstraZeneca H1 and Q2 2018 Results: Clinical Trials Appendix Q2 2018 results update: Movement since Q1 2018 update: New to Phase I (Additional indications): "oleclumab+AZD4635 (CD73 mAb + A2aR inhibitor EGFRm NSCLC)". (7/26)
¦Pluristem: Granted Key Patent in Japan for Treatment of GI Following Acute Radiation Exposure. Recent data from Fukushima University shows PLX-R18 cells significantly increased survival and enhanced the recovery of the GI tract after radiation exposure. (7/26)
¦“ú–{ƒvƒƒZƒX‰»Šw‰ï2018ƒTƒ}[ƒVƒ“ƒ|ƒWƒEƒ€Fu‘a…«ƒ^ƒO‚ð—p‚¢‚½Icatibant Acetate‚̇¬v‹v•Û‘å•ã(JITSUBO) (7/27)
¦‚»[‚¹‚¢CVCFSosei RMF1 (Ķˆã—Ãtƒ@ƒ“ƒh)‚©‚çPromethera Biosciences SA ‚Ö‚Ì“ŠŽ‘‚ðŽÀsB(7/27)
¦‘å“ú–{Z—F»–ò2019”N3ŒŽŠú ‘æ1Žl”¼ŠúŒˆŽZB–k•ÄCOPDŽ¡—ÃÜ(“±“ü3»•i)F2018”N“x1QŽÀÑF2‰­‰~(2017”N“x1QŽÀÑ1‰­‰~)A‘Œ¸ŠzF0‰­‰~A‘Œ¸—¦29.5%(–k•ÄŒ»’n’ʉ݃x[ƒX‘Œ¸—¦31.9%)A2018”N“x2Q—ÝŒv—\‘zF10‰­‰~Ai’»—¦F15.3%A2018”N“x’ÊŠú—\‘zF29‰­‰~B(7/27)
¦‘å“ú–{Z—F»–ò2019”N3ŒŽŠú ‘æ1Žl”¼ŠúŒˆŽZƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒR[ƒ‹‰¹º”zMF[Q&A2F–k•ÄCOPD“±“ü3•i–ڂɂ‚¢‚Ä]. (7/30up)
¦ClinicalTrials(NCT03381274): Phase 1b/2, Oleclumab(MEDI9447) EGFRm NSCLC Novel Combination Study. (MEDI9447 with Osimertinib or AZD4635, AZD4635 with MEDI9447). Research Site Status Change: California, Maryland: "Recruiting". Study Completion Change: "2021/12/14" (7/30update)
¦Heptares: We are now seeking to appoint an enthusiastic and motivated gIT Support Technicianh working in our expanding IT team. (7/30Closed)
¦JITSUBOF9ŒŽ21“ú‚É–k‚Æ‚Ò‚ (“Œ‹ž“s–k‹æ‰¤Žq)‚É‚ÄŠJ³‚¹‚Ü‚·Š”Ž®‰ïŽÐî•ñ‹@\ŽåẪZƒ~ƒi[‚É‚ÄA“–ŽÐEˆõ‚ªu‰‰(uƒyƒvƒ`ƒhŒ´–ò‚Ì»‘¢ƒvƒƒZƒXŠm—§‚Ü‚Å‚Ìl‚¦•û‚Æ‚»‚̃|ƒCƒ“ƒgvJITSUBO Œ¤‹†ŠJ”­•” •”’· ŽRú±‹MŽj)‚ðs‚¢‚Ü‚·B(7/31)
¦Imperial College London, Imperial Innovations: Graduation Ceremony of MiNA Therapeutics: "Robert Habib from MiNA Therapeutics receives the graduation award and shares company's


424: journey since joining Imperial Incubator." (7/31) ¦•Ä‘“Á‹–oŠè(Jitsubo)FPeptide Synthesis Method. (8/2ŒöŠJ) ¦SBIØŒ”F‚»[‚¹‚¢u‚â‚âŽã‹Cv‚ɂăJƒo[ŠJŽnBHeptaresŠJ”­ƒpƒCƒvƒ‰ƒCƒ“‚Ì’†’·Šú“I‚ÈŽ¡Œ±‚Ìi’»‚ÉŠú‘ÒB–Ú•WŠ”‰¿‚ð1,200‰~(Base casej‚Æ‚·‚éBBear caseF700‰~ABull caseF2,000‰~ABlue skyF3,500‰~AUltra Blue SkyF4,000‰~‚Æ‚µ‚Ä—˜_Š”‰¿‚ðŽZoB(8/2) ¦Miles Congreve (Heptares): My last day at BioPark, bring on Granta Park, Cambridge! (8/2) ¦SOSEIŠ”Žå’ÊMFu“ú–{‰‚Ì‘Û“I‚ȃŠ[ƒfƒBƒ“ƒOƒoƒCƒI»–òŠé‹Æ‚ð–ÚŽw‚µ‚ÄvF“–ŽÐ‚Í‘å‚«‚Ȭ’·‚ð‹‚°A“ú–{‰‚Ì‘Û“I‚ȃŠ[ƒfƒBƒ“ƒOƒoƒCƒI»–òŠé‹Æ‚Ö‚Ì“¹‚ð‡’²‚Éi‚ñ‚Å‚¢‚Ü‚·B2018”N3ŒŽŠú‚Í‚±‚ê‚Ü‚Å‚ÅÅ‚à‘å‚«‚Èi•à‚ð‹‚°‚½”N‚É‚È‚è‚Ü‚µ‚½B(8/6) ¦ŒÂ•ÊŠ”î•ñFSBIØŒ”‚Å‚ÍAHeptaresŠJ”­ƒpƒCƒvƒ‰ƒ“‚Ì’†’·Šú“I‚ÈŽ¡Œ±‚Ìi‚¿‚å‚­‚ÉŠú‘ÒB“¯ŽÐ‚ÌŽ–‹Æ‰¿’l‚ÍHeptares‚ÌŠJ”­ƒpƒCƒvƒ‰ƒCƒ“‚É‚ÄŒˆ‚Ü‚éB‚±‚ÌŠ”‰¿…€‚ÍAHeptaresƒpƒCƒvƒ‰ƒCƒ“‚ªŠJ”­‘O”¼í‚Å‚ ‚邱‚Æ‚ð‰Á–¡‚·‚é‚Æu“K³v‰¿Ši‚É—Ž‚¿’…‚¢‚Ä‚¢‚éB(8/6)



425:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 17:31:47.16 r9lyFCZD0.net
¦Heptares Twitter (Change Name): Heptares¨hSosei Heptaresh. (8/6 Changed)
¦‚ ‚·‚©»–ò •½¬31”N3ŒŽŠú‘æ1Žl”¼ŠúŒˆŽZFŽå—Í•i‚Ì”„ã‚F‹Ù‹}”ð”DÜ(ƒmƒ‹ƒŒƒ{)F“–Šú‘æ1Žl”¼Šú3.1‰­‰~(‘OŠú‘æ1Žl”¼Šú3.2‰­‰~)A‘ΑO”N“¯Žl”¼Šú‘Œ¸—¦¢1.6“A“–Šú”NŠÔŒ©ž12.6‰­‰~(‘OŠú”NŠÔŽÀÑ12.1‰­‰~) (8/6)
¦Medicinal Chemistry GRC: "Novel Adenosine 2A Receptor Antagonist AZD4635: From the Brain to the Tumor Microenvironment": Michelle Lamb, AstraZeneca USA. (8/6 Presented)
¦Oligonucleotide Therapeutics Society (OTS): The newest Paper of the Month is Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer. (8/6)
¦‰¢B“Á‹–(Sosei R&D)FTreatment of Respiratory Diseases. (8/8ŒöŠJ)
¦Pluristem Initiates Two Pivotal Phase III Studies in Israel. Numerous Clinical Sites in Israel to join sites in the U.S. and Europe for Pivotal Phase III Studies of PLX-PAD Cell Therapy in the Treatment of Critical Limb Ischemia and Muscle Injury Following Hip Fracture. (8/8)
¦SOSEI 2018”N12ŒŽŠú‘æ1Žl”¼ŠúŒˆŽZFŒ¤‹†ŠJ”­”ï1,826•S–œ‰~(69.5“‘‰Á) 97.3%‚͉p‘Šˆ“®Bƒvƒ‰ƒbƒgƒtƒH[ƒ€‚ðˆø‚«‘±‚«Šg[B“–ŽÐƒOƒ‹[ƒv‚Í13•i–Ú‚ª‘n–ò’iŠKA5•i–Ú‚ª‘O—Õ°ŽŽŒ±’†A4•i–Ú(ƒŒƒr[¬‘ÌŒ^”F’mÇ(DLB)Š³ŽÒ‚ð‘ÎÛ‚Æ‚µ‚½“ú–{‚É‚¨‚¯‚é‘OŠú‘æ‡U‘ŠŽŽŒ±‚ðŠÜ‚Þ)‚ª—Õ°ŽŽŒ±’†B(8/9)
¦ƒyƒvƒ`ƒhƒŠ[ƒ€ •½¬30”N6ŒŽŠúŒˆŽZFPAR2‚ɑ΂µA‚‚¢e˜a«‚Æ‘I‘ð«‚ð—L‚·‚éƒyƒvƒ`ƒhEƒAƒ“ƒ^ƒSƒjƒXƒg‚𓯒肵‚Ä‚¨‚èA‚±‚̃vƒƒOƒ‰ƒ€‚ÍŒ»ÝAHit-to-Lead‚̃Xƒe[ƒW‚É“ü‚Á‚Ä‚¨‚è‚Ü‚·B(8/9)
¦JITSUBOF“–ŽÐ‹Zp‚ÉŠÖ˜A‚·‚é˜_•¶‚ð’ljÁ‚µ‚Ü‚µ‚½BˆÈ‰º(“–ŽÐ‹ZpŠÖ˜A˜_•¶ƒy[ƒW)‚æ‚育Šm”F‚­‚¾‚³‚¢B(8/9)
¦•Ä‘“Á‹–oŠè(Heptares)FMuscarinic Agonists. (8/9ŒöŠJ)
¦ClinicalTrials(NCT03592862: HTL0018318-203): Phase 2, A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies (DLB). Locations(Add, Study Research Site): Kurumi Clinic(‚­‚é‚݃NƒŠƒjƒbƒN): "Recruiting", Tokyo, Japan. (8/9update.)
¦ƒAƒCƒtƒBƒXŠ”—\•ñF“úŒn‘åŽèØŒ”(‚Ý‚¸‚ÙØŒ”)A‚»[‚¹‚¢ƒŒ[ƒeƒBƒ“ƒO‹­‹C(”ƒ‚¢)Œp‘±B–Ú•WŠ”‰¿21,600‰~(5/18)¨5,400‰~B–Ú•WŠ”‰¿ƒRƒ“ƒZƒ“ƒTƒX‚Í3,278‰~(ƒAƒiƒŠƒXƒg”8l)B(8/9)
¦ƒAƒCƒtƒBƒXŠ”—\•ñF2018”N12ŒŽŠú ‹ÆÑ—\‘zƒRƒ“ƒZƒ“ƒTƒX(8/10


426:XV) ¦ReutersFSOSEI 2018-2022‹ÆÑ—\‘zƒRƒ“ƒZƒ“ƒTƒXB(8/10update) ¦Žl‹G•ñƒIƒ“ƒ‰ƒCƒ“Fˆã–ò¥ƒoƒCƒIƒxƒ“ƒ`ƒƒ[‚Ì•]‰¿‚ʼn½‚ªd—v‚©B‰Ÿ‚¦‚Ä‚¨‚­‚ׂ«3‚‚̃|ƒCƒ“ƒgB‚»[‚¹‚¢ƒOƒ‹[ƒvFˆêŽž‹à‚Ì”—ŽŒã‚Í‹ÆÑ‚ª’á–ÀBŠé‹Æ”ƒŽû‚ɑ΂·‚é–Ú—˜‚«—Í‚Í‚‚­•]‰¿‚³‚ꂽ‚à‚Ì‚ÌA“ÆŽ©ŠJ”­‚Í‚±‚ê‚©‚çA¡ŒãA–{“–‚̈Ӗ¡‚Å‚ÌŠJ”­—Í‚ª–â‚í‚ê‚é‹Ç–Ê‚É“ü‚Á‚Ä‚¢‚­B(8/13) ¦ClinicalTrials(NCT03592862: HTL0018318-203): Phase 2, A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies (DLB). Change Study Status: Not yet Recruiting¨"Recruiting". (8/13update.) EEE Heptares Event update: ¦CCP4BB Meeting Announcement:. The 32nd Rhine-Knee Regional Meeting on Structural Biology will take place in the heart of Switzerland in Emmetten from September 26 to 28. (8/13update) EThe Scientific Program Keynote Speakers: Dr. Andy Dore, Heptares Therapeutics, UK. EEE



427:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 17:32:50.82 r9lyFCZD0.net
¦SOSEI‚̬’·‘Šê‚Ì“®ŒüF[Š”Ž®4•ªŠ„F(6/27)•ªŠ„”ä—¦C³Ï]
2014/_4/25 (I’l_515) ”„Žc‚144800 ”ƒŽc‚_4212800 E(2014/_4/22ňÀ’l_464)¦[¬’·‰ñŽûŠú‚Ì“üŒû]ƒXƒe[ƒW‚Ö
2015/_2/20 (I’l_945) ”„Žc‚_56800 ”ƒŽc‚_6123200 E(2015/_3/16ňÀ’l_713)¦Heptares [¬Œ÷‚̘̓Xƒe[ƒW]
2015/10/30 (I’l1080) ”„Žc‚_45600 ”ƒŽc‚_8871600 E(2015/_9/24ˆÀ’l_888)¦•Ä‘³”F[ŽŸ‚È‚é”ò–ôƒXƒe[ƒW‚Ö]¦[㔲‚¯Œ—‚Ö]
2016/_4/25 (I’l5808) ”„Žc‚159200 ”ƒŽc‚13619600 E(2016_5/_9Å‚’l6545)¦Allergan[‹­‹C‘Šê]
2016/_6/24 (I’l3680) ”„Žc‚_42000 ”ƒŽc‚_9944400 E(2016/_6/24ˆÀ’l3240)¦[‹­‹C‘Šê‰ðœ]¦[ŽžŠÔŽ²‚Å‚Ì’²®‹Ç–Ê‚Ö]
2017/_3/31 (I’l2720) ”„Žc‚_22400 ”ƒŽc‚10487200 E(2017/_4/_4ˆÀ’l2570)¦[ŽžŠÔŽ²’²®‚͇’²‚É„ˆÚ]¦[U‚é‚¢êEE‚¢ê‚Ö]
2017/_9/_8 (I’l2175) ”„Žc‚__7600 ”ƒŽc‚_8151200 E(2017/_9/_6ňÀ’l2147)¦[E‚¢ê‚à‡’²‚É„ˆÚ]
2018/_1/26 (I’l3053) ”„Žc‚__3600 ”ƒŽc‚_5716400 E(1/22ˆÀ’l2740)¦[U‚é‚¢‚à‡’²‚É„ˆÚ]
2018/_3/_9 (I’l2378) ”„Žc‚_42000 ”ƒŽc‚_7177600 E(3/_5ˆÀ’l2195)¦[ˆ«’n‡‚¢‚É‚ÄÄ‚Ñ‚ÌE‚¢ê‚Ö]
2018/_6/29 (I’l1784) ”„Žc‚_____0 ”ƒŽc‚_7931600 E(6/20ˆÀ’l1595) ¦‹ó”„‚艿Ši‹K§ƒgƒŠƒK[(5/11ˆÀ’l1665, 6/5ˆÀ’l1695)
2018/_7/_6 (I’l1387) ”„Žc‚__7300 ”ƒŽc‚_7728300 E(7/_5ˆÀ’l1304) ¦‹ó”„‚艿Ši‹K§ƒgƒŠƒK[(7/2ˆÀ’l1584, 7/3ˆÀ’l1414)
2018/_7/13 (I’l1412) ”„Žc‚__6800 ”ƒŽc‚_7479600 E(7/11ˆÀ’l1342)
2018/_7/20 (I’l1329) ”„Žc‚_10700 ”ƒŽc‚_7489500 E(7/20ˆÀ’l1308)
2018/_7/27 (I’l1422) ”„Žc‚__6600 ”ƒŽc‚_7579800 E(7/23ˆÀ’l1325)
2018/_8/_3 (I’l1369) ”„Žc‚__6600 ”ƒŽc‚_7358300(-221500) E(8/_2ˆÀ’l1366)
2018/_8/10 (I’l1369) ”„Žc‚__6600 ”ƒŽc‚_7101500(-256800)¦8/14up E(8/8ˆÀ’l1366)
2018/_8/13 (I’l1255) 5“úü˜¨—£(-7.31“) 25“úü˜¨—£(-9.09“) 75“úü˜¨—£(-23.02“) 200“úü˜¨—£(-42.92“) (ˆÀ’l1250)
2018/_8/14 (I’l1237) 5“úü˜¨—£(-6.30“) 25“úü˜¨—£(-9.94“) 75“úü˜¨—£(-23.76“) 200“úü˜¨—£(-43.58“) (ňÀ’l1213)¦[”N‰—ˆˆÀ’lXV]
X‚Ȃ鬒·‚Ìêt–¾Šú‚É‚ÄA‹­‹C‘ŠêŒã‚ÌŽžŠÔŽ²‚Å‚Ì’²®I”Ղ͇’²‚É„ˆÚBÎB
¬’·í—ª‚à‡’²E’…ŽÀ‚Èi“W‚ÅAŽŸ‚È‚é“WŠJEi’»‚ªŠy‚µ‚Ý‚Å‚·‚ËBÎB

428:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 18:04:02.17 CycfJUMmp.net
3–œ‚Ȃ甄‚肽‚¢‚Æ‚©Œ¾‚Á‚Ä‚½‚æ‚ËA¡‚È‚ç7500‰~‚©

429:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 18:35:57.56 CvmrI93e0.net
‹Ž”N‚ÌŠCŠO‘Ž‘‚Ì•ª‚à”¼’l‚©
‚¨‚»‚ç‚­‚Ù‚Æ‚ñ‚Ç‚ª‘¹Ø‚肳‚ê‚Ä‚é‚ÆŽv‚¤‚ªBBB
“ñ“x‚ÆŠCŠO‚Ńtƒ@ƒCƒiƒ“ƒX‚Í‚Å‚«‚È‚¢‚È
ƒiƒXƒ_ƒbƒN‚È‚ñ‚Ä‚ ‚é‚킯‚Ë‚¦‚æ

430:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 18:40:25.28 6EJhTljQd.net
•ß‚Ü‚Á‚Ä‚é‚â‚‚¢‚é‚Æ‚µ‚½‚ç‘嬌÷‚Å‚â‚Á‚Æ”ƒ’l‚É–ß‚éƒJƒ“ƒW‚¾‚©‚ç‚à‚¤“ñ“x‚ÆŸ‚¿‚Í–³‚¢‚Ë

431:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:02:32.21 Dup+K2DIk
ˆ«Þ—¿–³‚µ‚Å‚T•ª‚Ì‚P‚¾‚©‚ç‚Ë
DÞ—¿–³‚µ‚Å‚à‚T”{‚É‚Í‚È‚é‚Á‚ÄŽ–‚¾‚ë
ƒSƒ~ƒ^ƒCƒˆƒE‚æ‚èˆÀ‚­”ƒ‚¦‚é‚Æ‚È‚ê‚Î
ŽŸ‚Í‚Ç‚ñ‚ȃtƒ@ƒ“ƒh‚ª‘å—Ê•Û—L‚µ‚Ä‚­‚é‚Ì‚©Šy‚µ‚Ý‚¾

432:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:09:31.19 Gnel3lWS0.net
PTS‘å–\—Žw

433:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:13:29.24 Gnel3lWS0.net
13“ú ƒ‚ƒ‹ƒKƒ“14–œŠ”‚à‹ó”„‚èIIIII
‚±‚ê‚©‚ç‚Ç‚ñ‚Ç‚ñ”„‚è‘‚µ‚ÄŠ”‰¿2Œ…‚ÉIII
‹ó”„‚èŠOŽ‘‚ð‚È‚ß‚é‚È‚æƒ{ƒP

434:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:14:00.83 Gnel3lWS0.net
14–œ‚¶‚á‚È‚¢A16–œŠ”‚Ì‚©‚炤‚肶‚á

435:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:18:36.74 Gnel3lWS0.net
”ƒ‚¢“؂Ƀ‚ƒ‹ƒKƒ“‚Ì–³ŒÀ‹ó”„‚è–C‚ªP‚¤w

436:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:23:27.54 Dup+K2DIk
”„‚Á‚Ä‚½‚Ì‚ª‚QŒ…‚©‚ç‚´‚ñ‚´‚ñ“¥‚Ýã‚°‚ç‚ê‚Ä‚é‚l‚t‚e‚f‚È‚ç‹t‚ɈÀS
‘Ï‹v—Í–³‚¢‚©‚瑼‚ÌŠOŽ‘‚Ì—Ç‚¢ƒJƒ‚

437:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:25:14.36 +vBRWhQuM.net
‚¨–~‚·‚°‚¦‚È
’n–‚Ì’ê‚©‚çƒLƒ`ƒKƒC~—Õ‚µ‚Ă邶‚á‚ñ

438:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:32:10.59 L9qV9g5/.net
ƒoƒJƒ‹ƒT‚ª”ƒ‚¢ø‚肵‚Ä‚½Žž‚Æ“¯‚¶‚¾‚È‚—
ƒRƒƒRƒƒ`ƒƒƒ“ƒRƒƒoƒJƒ‹ƒT[iÎj

439:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:37:14.36 L9qV9g5/.net
‚Ç‚¤‚µ‚Ä‚à‰¼‘z“G‚ª—~‚µ‚¢
‚»‚ê‚ð’@‚­‚±‚Æ‚Å‹ð‚©‚ÈŽ©•ª‚𳓖‰»o—ˆ‚é
‚Ü‚é‚ÅŽx“ß‚â’©‘N‚̂悤‚É
‚»[‚¹‚¢ƒ‹ƒTƒ“ƒ`ƒƒ“ƒY‚Ì’Pƒ‚ÈŽvl‚Æ“¯‚¶iÎj

440:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:44:43.20 L9qV9g5/.net
’´ƒoƒJƒ‹ƒT—ñ“`iÎj

441:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 19:45:58.88 gqvBQb9+0.net
M—p”ƒŽc‚èAæT‚¾‚¢‚ÔŒ¸‚Á‚½‚È[

442:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:01:48.93 Tlc9qjtQ0.net
•ªŠ„‘O…€‚ÅŒ©‚邽‚ß‚É4‚ÅŠ„‚Á‚Ä‚ÝH
‚Ü‚¾180–œŽã‚à‚ ‚é‚ñ‚¾‚¼w

443:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:09:34.84 Dup+K2DIk
ƒoƒCƒI‚Å‚o‚a‚q‚P”{‚Íãê”pŽ~Œœ”O‚Å‚à‚È‚©‚È‚©‚¢‚©‚È‚¢
‚±‚±‚©‚ç‚͘VŽá’j—–â‚킸–³ŒÀ‚É‹ß‚¢”ƒ‚¢Žx‚¦‚ª“ü‚邾‚낤

444:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:20:39.07 gqvBQb9+0.net
‚¢‚âA‚Å‚àˆêŽžŠú‚É”ä‚ׂ½‚炾‚¢‚ÔŒ¸‚Á‚½‚ÆŽv‚¤‚íB
180–œ‚ÍŠm‚©‹Ž”N‚Ìtæ‚­‚ç‚¢‚Ì…€‚âB

445:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:20:42.58 fdcmvZvea.net
M—p”ƒ‚¢‚Ì‘½‚³‚ðø‚é‚Ì‚à‚¢‚¢‚ªA
‹ó”„‚è‚Ì”‚àl—¶‚µ‚È‚¢‚Æ‘Ê–Ú‚¶‚á‚ËH
‰º‚ª‚镪‚Í’ú‚ß‚½‚¯‚ÇA”ƒŽû‚³‚ê‚é‚Ì‚ªˆê”ÔŒ™‚¾‚È
‚ÜA‚±‚±‚Ü‚Å—ˆ‚½‚玡Œ±Œ‹‰Ê‚Ü‚Å—lŽqŒ©‚©‚ÈB‚»‚ê‚܂ʼn¿’l‚ÍŒˆ‚ß‚ç‚ñ‚È‚¢

446:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:24:40.63 Gnel3lWS0.net
ƒ‚ƒ‹ƒKƒ“‚Í“O’ê“I‚É‚â‚é‚æ
’†“r”¼’[‚Í‚µ‚È‚¢
”½R‚µ‚Ä‚Í‚¢‚¯‚È‚¢

447:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:30:22.38 Dup+K2DIk
‚¢‚‚â‚é‚ñ‚¾‚æH
‚P‚O”NˆÈã‚¢‚Ä”„‚èŽc‚P“‚Á‚ÄŒÂl‚æ‚èŽã‚¢‚¶‚á‚Ë‚¦‚©‚—

448:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:29:20.93 ZV5bXnCfr.net
‚à‚¤2000‰~‚Å”ƒŽû‚Å‚¢‚¢‚íƒMƒŠƒMƒŠ—˜‰vŠm’èo—ˆ‚é‚©‚ç
‚à‚µ‚­‚̓eƒXƒ‰‚Ý‚½‚¢‚ɃTƒEƒWƒAƒ‰ƒrƒA‚©‚炨‹àŽØ‚è‚Ä”ñŒöŠJ

449:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:32:39.43 U6Io4AzX0.net
‚±‚Ì…€‚ʼnº‚°Ž~‚Ü‚Á‚Ä‚àƒLƒŠ‚ªˆ«‚¢‚Ì‚ÅA‚Ç‚¤‚¹‚È‚ç
2015”N10ŒŽ‚Ì950‰~‚܂ʼnº‚°‚ÄŽdØ‚è’¼‚µ‚½‚Ù‚¤‚ª—Ç‚¢‹C‚ª‚·‚é

450:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:37:46.01 Dup+K2DIk
Ž‚Á‚Ä‚È‚¢‚Ì‚É”ƒŽû‚µ‚Ä—~‚µ‚¢‚ñ‚¾H‚ß‚¸‚炵‚¢”„‚èø‚肾‚Ë

ƒnƒCƒJƒ‰ƒoƒJƒ‹ƒT‚̃yƒ‰‚¢–½‚Ìd‚³BÎB

451:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:42:35.87 ozLzQMwt0.net
‚Ù‚Ú‘SŠ”—˜‚ªæ‚Á‚Ä‚é‹ó”„‚è‚Æ‚Ù‚Ú‘SŠ”–c‘å‚ÈŠÜ‚Ý‘¹‚ÌM—p”ƒ
”‚Ì‘½‰Ç‚¾‚¯‚ÅŒê‚ê‚È‚¢‚¾‚낤‚È‚»‚è‚á

452:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:46:23.01 Dup+K2DIk
ƒoƒJƒ‹ƒT‚Í‚¨–~‚à’N‚Æ‚à‰ï‚¦‚¸‚ЂÁ‚»‚è‚ÆŒfŽ¦”‚̒†‚ʼn߂²‚·‚ñ‚¾‚낤‚ÈB
ƒnƒCƒJƒ‰‚Í‚P“ú‚Å“¥‚Ýã‚°‚ç‚ê‚Ä’ÇØ”‰­”­¶‚·‚é‚©‚í‚©‚ç‚È‚¢


453:l‚¾‚©‚ç‚ÈBŒû‚ðŠJ‚¯‚Α¼l‚Ì•sKƒƒVƒEƒ}”­Œ¾A’N‚à‚©‚©‚í‚È‚ç‚È‚¢‚悤‚É‚µ‚Ä‚¢‚é‚ñ‚¾‚낤BŒÇ“ƃoƒJƒ‹ƒTBÎB



454:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 20:51:06.06 fdcmvZvea.net
‚»‚ñ‚È‚É’Pƒ‚¶‚á‚È‚¢‚ÆŽv‚¤‚ªB

455:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 21:07:40.10 Fnf3X7w90.net
‚±‚Ì’f–––‚‚Ì’†‚Å‚à
ŽÐ’·‚Í’n’†ŠC‚Æ‚©‚ŃoƒJƒ“ƒX‚©‚È
Š””ƒ‚Á‚Ä‚à‚炤‚悤¢ŠE’†‹í‚¯‚¸‚è‰ô‚Á‚Ä‚±‚»
‚‚¢•ñV‚ÉŒ©‡‚¤‚ÆŽv‚¤‚ñ‚¾‚ªBBB

456:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 21:20:01.66 Gnel3lWS0.net
ƒ‚ƒ‹ƒKƒ“—l–¾“ú‚à20–œŠ”‚®‚ç‚¢‹ó”„‚è‚©‚Ü‚µ‚Ä‚â‚Á‚Ä‚­‚¾‚³‚¢‚È!
10000–œŠ”ˆÈã‹ó”„‚肵‚ÄŠ”‰¿1Œ…‚É‚µ‚悤‚º

457:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 21:25:46.56 L9qV9g5/.net
ƒoƒJƒ‹ƒT[iÎj
ƒAƒzƒ‹ƒT[iÎj
ƒoƒJƒ‹ƒTƒeƒNƒjƒbƒNiÎj

458:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 21:34:44.20 Dup+K2DIk
“ª‚Ì‚¨‚©‚µ‚¢ƒoƒJƒ‹ƒT‚ª—Bˆê‚©‚Ü‚Á‚Ä‚à‚炦‚éêŠB‚»‚ꂪ‚Q‚¿‚á‚ñ‚Ë‚éBÎB

459:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 21:33:50.36 9jexYpGOx.net
‚¨‚Ü‚ç‚È‚É‚â‚Á‚Ä‚ñ‚¾‚©
ƒoƒCƒI‚ÍH‚ÌŠw‰ï‘O‚É”ƒ‚¤ƒZƒNƒ^[‚¾‚æ

460:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 21:43:20.13 Dup+K2DIk
ƒhƒCƒcƒŒ[ƒeƒBƒ“ƒOXV
–ñ‚R”{‚—”„‚è“؃Iƒƒ^

461:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 21:53:44.89 e3mLljpM0.net
­‚µ‚Å‚àƒ‚ƒ‹ƒKƒ“MUFG‚É‘ÎR‚·‚邽‚ßAŽO•HŠÖ˜A•s”ƒ‰^“®‚Æ‚©‹N‚±‚³‚ñ‚Ì‚©H
”¼•ªƒ‚ƒ‹ƒKƒ“‚Å‚àA‚à‚¤”¼•ª‚Í“ú–{Šé‹Æ‚Ì•È‚ÉŽO•H‚ª‹ó”„‚Á‚Ä‚ñ‚¾‚¼

462:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 22:02:33.93 Dup+K2DIk
‚P“‚̬ŽÒ‚Æ‚©‘S‚­‰e‹¿–³‚¢‚¯‚Ç‚È
‰É‚‚ԂµƒIƒ‚ƒ`ƒƒ‚É‚Í‚¿‚傤‚Ç‚¢‚¢

463:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 21:59:17.93 17o4RfhGr.net
‹ó”„‚肵‚Ä‚é‚̂̓‚ƒ‹ƒKƒ“‚ðŽg‚Á‚Ä‚éƒwƒbƒWƒtƒ@ƒ“ƒh‚¾‚©‚ç

464:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 22:06:03.16 Dup+K2DIk
‚‚Ȃª‚è‚Í–³‚¢‚ÆŽv‚¤‚¯‚Ç‚ ‚é‚È‚ç
‚i‚oƒ‚ƒ‹ƒKƒ“‚É‘å—Ê‚É”ƒ‚킹‚éˆ×‚ÌŒ©‚¹”„‚è•Û—L‚¾‚Á‚½‚Æ‚¢‚¤‚±‚Æ‚É‚È‚é‚Ë

465:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 22:22:23.02 Fnf3X7w90.net
‚ ‚܂茾‚¢‚½‚­‚È‚¢‚¯‚Ç
‚ ‚̃Aƒ“ƒWƒFƒX‚ÉŽž‰¿‘Šz”²‚©‚ê‚é‚©‚à‚µ‚ê‚È‚¢B

466:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 22:46:08.81 Gnel3lWS0.net
>>442
‚Ü‚ŸŽžŠÔ‚Ì–â‘è‚â‚ë‚È
ƒAƒ“ƒWƒFƒX‚Ì•û‚ª«—ˆ«‚ ‚é‚æ
‹C‚¢‚Ä‚È‚¢l‘½‚¢‚¯‚Ç
‚»[‚¹‚¢‚̓_ƒ‚¾‚æ

467:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 22:57:23.75 Dup+K2DIk
ˆêu‚ÅŽ€‚Ë‚éƒnƒCƒJƒ‰ƒoƒJƒ‹ƒT‚Æ‚Í‘åˆá‚¢‚¾‚È

468:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 23:07:23.12 fwfQTUXqd.net
36ƒŒƒX‚Á‚Ä‚Ç‚ñ‚¾‚¯•KŽ€‚È‚ñ‚¾‚æw

469:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 23:20:34.95 vrofbklwM.net
DLB¬Œ÷‚µ‚½‚çŒÜ–¡‚³‚ñ‚ÌŽ‘ŽY1000‰­‚¾‚ë

470:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 23:31:02.97 Gnel3lWS0.net
>>446
¬Œ÷‚µ‚Ä‚àƒ‚ƒ‹ƒKƒ“A–쑺—l‚ª‰Ÿ‚³‚¦‚‚¯‚é‚©‚ç‘åä•vBŠ”‰¿‚Íオ‚ç‚È‚¢

471:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 23:41:06.42 jDa7cG6M1
‚c‚k‚aŽ¸”s‚µ‚Ä‚à‘¼‚Ì•¨‚̃tƒ@ƒ“ƒ_‚¾‚¯‚Å‚P‚O‚O‚O‰­‚Í‚¶‚イ‚Ô‚ñ‰Â”\‚Å‚µ‚å
‚U‚O‚O‚O‰~‚ÌŽž‚Í‚c‚k‚a‚È‚ñ‚Ä–³‚©‚Á‚½‚ñ‚Å‚·‚©‚ç‚Ë
‚±‚±‚܂ʼn䖂µ‚½‚ñ‚¾‚©‚ç‹C‡‚Å‚P’›‚Ü‚ÅŽ‚Ä‚él‚È‚Ì‚©‚à‚µ‚ê‚Ü‚¹‚ñ‚Ë

472:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 23:37:48.01 uCe//qBd0.net
‚í[¦‚¢‚È[B”ƒ‚¢•û‚Ì‹@ŠÖ‚âƒtƒ@ƒ“ƒ_‚È‚ñ‚ÄŠÖŒW‚È‚¢‚ñ‚¾‚ËB
‚«‚Á‚Æ“¥‚Ýã‚°‚È‚ñ‚Ä‚³‚ꂽŽ–‚È‚¢‹@ŠÖ—l‚È‚ñ‚¾‚낤‚ËB

473:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 23:44:32.43 jDa7cG6M1
ƒnƒCƒJƒ‰ƒoƒJƒ‹ƒT‚Í–¾“úŽ€‚Ê‚©‚à‚µ‚ê‚È‚¢‚©‚猾‚¢‚½‚¢•ú‘è‚È‚ñ‚Å‚·‚æB

474:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 23:39:40.46 6EJhTljQd.net
‹t‚ɃEƒ‹ƒgƒ‰ƒnƒCƒp[’´âÞ—¿o‚ċ󔄂肵‚Ă銑S•”“|ŽY‚Å‚»[‚¹‚¢”­¢ŠE‹°Q‚Ȃ猩‚Ä‚Ý‚½‚¢

475:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/14 23:47:55.97 uCe//qBd0.net
‚¢‚âA‚»‚ê‚à‚Ç‚¤‚¾‚낤B‘S‘Ì‚ª—Ž‚¿ž‚Ü‚ê‚é‚Æ‘ÛÌr‚ê‚Æ‚©•|‚¢‚µB
V–ò‚àŠJ”­‚³‚ê‚È‚¢‚Æ«—ˆ¢‚é‚©‚çA³’¼’öX‚É‚µ‚Ä—~‚µ‚¢B

476:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 00:30:24.72 CizuQsNQ0.net
¦Vaccinex: Form 10-Q VACCINEX, INC. For: Jun 30. (SEC Filings: VACCINEX, INC. filed this Form 10-Q on 08/14/2018). (8/14)
1. hCOMPANY AND NATURE OF BUSINESSh
Description of Business:
Vaccinex, Inc. (together with its subsidiaries, the gCompanyh) was incorporated in Delaware in April 2001 and is headquartered in Rochester, New York.
The Company is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders.
EEE
6. hCOLLABORATION AGREEMENTSh
Heptares Therapeutics, Ltd.:
In June 2018, the Company entered into a research service agreement with Heptares Therapeutics, Ltd. (gHeptaresh) to provide research services to Heptares.
Under the agreement, Heptares will provide the Company compounds, materials or samples, and the Company will perform feasibility services to allow Heptares to evaluate the feasibility of the Companyfs technology.
The Company will receive payment from Heptares for services provided.
The Company has not received any service payment as of June 30, 2018.
The agreement can be terminated by either party on thirty daysf notice upon the completion of the research services.
URLØݸ(ir.vaccinex.com)

477:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 01:08:22.24 zoYaX+Tn0.net
>>446
‰½”{‚¾‚æH

478:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 04:44:21.29 QSPe5Dqz0.net
‚±‚±‚Ì‚Æ‚±‚ë‚ÌŠ”‰¿‰º—Ž‚Ì——R‚È‚ñ‚ÄAŠ‘FA‚»[‚¹‚¢‚Ìi‚Æ‚¢‚¤‚©ƒoƒCƒI‚ÌjŽ–‹Æ“à—e‚ð—‰ð‚Å‚«‚È‚¢ØŒ”‰ïŽÐ‚âV•·ŽÐ‚ªŒã•t‚¯‚Å‚±‚¶‚‚¯‚Ä‚¢‚邾‚¯‚Å‚µ‚åB
‰ïŽÐ”á”»AŽÐ’·”á”»‚ð‚µ‚½‚¢‹CŽ‚¿‚Í\•ª‚í‚©‚邯‚ÇA‰ïŽÐ‚©‚çIR‚ªo‚È‚¢’†‚Å‚±‚ñ‚È‘›‚¬‚ð‚µ‚Ä‚¢‚é‚Æ‚Ü‚¾ŠÃ‚¢–¨‚ªŽc‚Á‚Ä‚¢‚é‚ÆŽv‚¤”y‚ª‚±‚ê‚©‚ç‚à‚Ç‚ñ‚Ç‚ñW‚Ü‚Á‚Ä—ˆ‚é‚悤‚È‹C‚ª‚µ‚ÄA³’¼‚Ç‚¤‚È‚ñ‚¾‚낤‚Á‚Äl‚¦‚Ä‚µ‚Ü‚¤‚Ì‚ÍŽ„‚¾‚¯‚Å‚µ‚傤‚©H

479:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 06:13:00.42 Qc6PAbXO0.net
>>455
ˆÓ–¡•s–¾B‚h‚q‚Ío‚Ă邾‚ëB1`2”N‚͉½‚à‚ ‚è‚Ü‚¹‚ñIo‚¹‚Ü‚¹‚ñI‚Á‚ÄB

480:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 06:41:41.20 YLCtgi5W0.net
‚»‚ñ‚ÈIR‚Ío‚Ä‚È‚¢‚¯‚ÇB‰½‚à‚È‚¢‚Æ‚©o‚¹‚È‚¢‚Æ‚©‚àŒ¾‚Á‚Ä‚È‚¢B
‚Æ‚¢‚¤‚©ƒ}ƒCƒ‹‚⓱o‚ðŒ©ž‚ß‚é—ˆ”N“x‚Ü‚ÅŒã4ƒ–ŒŽ‚¿‚å‚Á‚Æ‚¾‚ºB
‚Æ‚Í‚¢‚¦Mina‚ÌŒ‹‰Ê‚܂Ńpƒ[ƒvƒŒƒC‘±‚­‚ñ‚¶‚á‚È‚¢‚©‚ÈB

481:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 07:24:51.01 iQwPD7nJV
‚»‚ë‚»‚ë‚l‚h‚m‚`”ƒŽû‚Ìî•ñ‚Å‚ào‚Ä‚­‚é‚Ì‚©‚ÈH
”•S‰­Šé‹Æ‚ª”•S‰­Šé‹Æ‚Ì”ƒŽû‚¾‚©‚çˆê”g—‚ ‚è‚»‚¤‚¾‚Ë

482:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 07:32:34.41 iQwPD7nJV
­‚È‚­‚Æ‚à‚l‚h‚m‚`‚ªƒwƒvƒ^ƒŒƒX‚Ý‚½‚¢‚ɉ½‚ÌŠ”‰¿


483:vŒ£‚à‚µ‚È‚¢Šé‹Æ‚¶‚á‚È‚¢‚±‚Æ‚ð‹F‚é‚悵‚©‚µAƒpƒCƒvƒ‰ƒCƒ“‚ªƒSƒƒSƒ‚¢‚Á‚Ï‚¢‚ ‚邯‚lj½ˆ‚©‚çE‚Á‚Ä‚«‚½‚ñ‚¾‚Á‚¯H–Y‚ê‚¿‚á‚Á‚½



484:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 07:33:24.80 tVeP7JyyM.net
>>453
chi‚³‚ñ‰³
Ž¡Œ±‚Ìi’»‚Í–Ú‚ðáÒ‚Á‚Ä‚½‚¯‚Ç‚±‚ê‚ÍŠJŽ¦‚µ‚È‚¢‚ƃ_ƒ‚¾‚ë

485:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 07:34:28.32 kSLhfO/K0.net
>>460
“à—e‚ð‹³‚¦‚Ä’¸‚¯‚Ü‚·‚©H

486:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:08:50.70 V9HarClld.net
‚·‚é•K—v‚È‚¢‚¯‚Çw

487:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:10:11.32 +w1QyRaHr.net
ƒgƒ‹ƒR‚ʼnº‚°‚½•ª‚Í–ß‚·‚¾‚ë
1400‰~‚Ü‚Å‚È

488:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:13:56.40 SbRfKJw7a.net
¡‚ÌŠ”‰¿‚Í‚·‚ׂĂ̬Œ÷D‚èž‚ñ‚Å‚é‚©‚çˆê‚Â‚Å‚àŽ¸”s‚µ‚½‚犔‰¿‚Í2Œ…‚ɂȂ邾‚낤

489:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:21:58.83 V9HarClld.net
ƒeƒ‰‚Ý‚½‚ç‚í‚낽

490:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:25:44.35 SbRfKJw7a.net
ƒAƒ“ƒWƒFƒX‚ÉŽž‰¿‘Šz”²‚©‚ê‚»‚¤wwwww

491:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:29:03.52 iQwPD7nJV
ƒAƒ“ƒWƒFƒXƒCƒiƒSƒtƒ‰ƒO‚©‹ó”„

492:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:27:49.14 1MPffOi40.net
¡“ú‚àA‚Ç[[[‚ñB

493:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:32:05.64 SbRfKJw7a.net
ƒ‚ƒ‹ƒKƒ“—l‘å—Ê‚É‹ó”„‚è‹Ê—pˆÓ‚µ‚Ä‘Ò‚¿\‚¦‚Ă邼w
Šñ‚肪‚‚¯‚ê‚΂‚¢‚Ù‚Ç”ü–¡‚µ‚¢‚ÆŽv‚Á‚Ä‚é‚æ

494:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:35:31.97 KssVqtAH0.net
>>460
‚Ç‚ñ‚È“à—eH

495:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:39:19.59 JU69amWfx
‚»[‚¹‚¢‚É‚Æ‚Á‚Ä“s‡‚̈«‚¢î•ñ‚ÍA
‰B•Á‚³‚ê‚éB
ãŽè‚­‚¢‚Á‚Ä‚È‚¢‚ñ‚Å‚µ‚åB

496:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:41:14.73 iQwPD7nJV
ƒnƒCƒJƒ‰ƒoƒJƒ‹ƒT–½‚ª‚¯BÎB

497:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:46:13.11 SbRfKJw7a.net
‹C”z‰º‚ª‚Á‚Ä‚«‚½‚æw

498:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:46:34.76 SbRfKJw7a.net
>>470
‚Ü‚½‚çÔŽš‚ª‘‚¦‚é“à—e

499:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:50:01.19 SbRfKJw7a.net
‹C”zƒ}ƒC“]ww

500:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:54:38.55 iQwPD7nJV
‚©‚í‚¢‚»‚¤‚ȃLƒ`ƒKƒC‚¾‚È

501:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:54:26.46 SbRfKJw7a.net
‹C”z‘å–\—Žwww

502:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 08:55:04.50 SbRfKJw7a.net
¡“ú‚àƒ‚ƒ‹ƒKƒ“—l–{‹C‚Å‚·

503:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:03:31.01 iQwPD7nJV
ƒnƒCƒJƒ‰ƒoƒJƒ‹ƒTIN–h‹óˆ

504:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:02:35.88 LZDZT36h0.net
1250‚Å‹ó”„‚è‚¢‚¢‚¢‚¢I

505:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:04:34.31 LZDZT36h0.net
100Š”‚ ‚½‚è160‰~‚ňÀ‚­ƒJƒ‰”„‚è‚Å‚«‚邼I݌ɂà3–œŠ”‚ ‚èIâ‘Îオ‚ç‚È‚¢‚©‚甄‚Á‚Ä‚¨‚¯II—]—T‚ÅŸ‚Ă邼

506:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:10:29.24 iQwPD7nJV
‚VŒ…Þ—¿‚Å–{“ú’†‚É‘¦Ž€‚Å‚«‚éƒnƒCƒJƒ‰ƒoƒJƒ‹ƒTBÎB

507:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:10:29.92 5UVjNkl90.net
ƒGƒA‹ó”„‚肤‚º‚¦

508:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:10:53.89 LZDZT36h0.net
ƒJƒ‰”„‚è—]—T‚·‚¬‚í‚낽w–³ŒÀ‚ÉŸ‚Ä‚é‚í

509:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:11:13.10 Qc6PAbXO0.net
‚»[‚¹‚¢ƒs[ƒ^[ŽÐ’·
”NŽû3‰­6200–œ‰~
‘æ5ˆÊ‚¨‚ß‚Å‚Æ‚¤I
‚»[‚¹‚¢ƒAƒ“ƒhƒŠƒ…[‘O•›ŽÐ’·
”NŽû1‰­5500–œ‰~
‘æ19ˆÊ‚¨‚ß‚Å‚Æ‚¤I
‚»[‚¹‚¢ƒ}ƒ‹ƒRƒ€•›ŽÐ’·
”NŽû1‰­2000–œ‰~
‘æ32ˆÊ‚¨‚ß‚Å‚Æ‚¤I
‚»[‚¹‚¢“c‘º‰ï’·
”NŽû1‰­1400–œ‰~
‘æ37ˆÊ‚¨‚ß‚Å‚Æ‚¤I
URLØݸ(answers.ten-navi.com)

510:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:12:20.54 LZDZT36h0.net
‚±‚±2”NŠÔ‚̃}ƒC“]‚·‚éŠm—¦‚Í‚»[‚¹‚¢ ‚Í89%‚¾‚µ‚Èwww‚±‚êƒ}ƒW‚¾‚©‚ç

511:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:15:06.08 LZDZT36h0.net
”NŠÔ10‰­ˆÈã–ðˆõ‚É•¥‚Á‚Ä‚é‚ÌHƒoƒJ‚¾‚ëÔŽš‚È‚Ì‚ÉB‘Ž‘‚Å–ðˆõ‚Ì‹‹—¿•¥‚Á‚Ä‚é‚ñ‚Å‚µ‚åÎBŠ”‰¿–³‚­‚È‚é‚ñ‚¶‚á‚ËÎ

512:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:21:32.65 Ne5TXfvb0.net
•M“ªŠ”Žå‚Å‚ ‚éŒÜ–¡‚̓s[ƒ^[‚Ì‚Šz•ñV‚É•¶‹å‚𥂦‚Ä‚¢‚È‚¢‚ñ‚¾‚Á‚½‚çŽã¬‚Ì‚¨‘O‚犔Žå‚ª‰½‚ðŒ¾‚¨‚¤‚ªŽæ‚è“ü‚ê‚Ä‚­‚ê‚È‚¢
‚»‚ꂪŽ‘–{Žå‹`‚È‚ñ‚¾‚æ
•¶‹å‚ðŒ¾‚¢‚½‚¢‚̂Ȃ犔‚𔃂¦

513:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:36:13.63 fEAAUK/Dr.net
>>486
ƒƒƒ^
¡“ú‚̓}ƒCƒeƒ“‚µ‚Ä‚È‚¢‚©‚çŽc‚è‚Ì11%‚Ì“ú‚©

514:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:38:48.69 V9HarClld.net
ƒo[ƒ`ƒƒƒ‹‹ó”„‚èw

515:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:39:21.33 KssVqtAH0.net
‰ïŽÐ‚ÍŠ”‰¿‘Îô


516:‚µ‚È‚¢‚ÌH



517:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:40:12.28 lo1ypJ9ha.net
>>481
‹à‚ª—Ž‚¿‚Ä‚é‚悤‚È‚à‚ñ‚¾‚È
ƒnƒCƒJƒ‰‚Å100ƒp[ƒZƒ“ƒgŸ‚Ä‚é‚Ì‚É

518:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:40:36.26 lo1ypJ9ha.net
>>491
o—ˆ‚éƒlƒ^‚ª–³‚¢

519:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:44:30.32 1MPffOi40.net
ƒ^ƒJƒ‰‚΂¢‚¨âD’²I@‚»[‚¹‚¢ƒoƒCƒI‚Ç‚¤‚µ‚½‚ÌH

520:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:47:06.82 llIbhqQzr.net
‚»‚ë‚»‚딽“]‚µ‚Ä100‰~‚®‚炢グ‚ë‚â
¡‚܂ł̉º‚°‚É”ä‚ׂê‚Α債‚½Ž–‚Ë[‚¾‚ë

521:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:50:39.04 B93VS0CVa.net
>>491
—ˆ”N‚·‚é‚Á‚Ä‚³

522:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 09:53:43.70 zaChqiXD0.net
ŒÜ–¡‚Ç‚¤‚·‚é‚ñ‚¾‚낤‚È
ƒiƒ“ƒsƒ“‚Æ‚©ƒ}ƒWƒoƒJ

523:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:01:33.53 HnakyoCc0.net
‘Šê‚ª•ö‚ê‚é‚Æ•’Ê‚É10%‚Æ‚©‰º‚°‚é‚Ì‚É‚»‚ÌŒã‘S‘R–ß‚ç‚È‚¢‚Ì‚ª‚·‚²‚¢

524:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:09:46.81 iQwPD7nJV
‰°•aŽÒ‚ª–h‹óˆ‚©‚çŠO‚Éo‚é‹@‰ï‚ð‚¤‚©‚ª‚Á‚Ä‚¢‚é

525:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:07:04.49 GZ68lGH50.net
‚ñ‚ 

526:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:08:10.44 LZDZT36h0.net
‚Í‚¢ƒ}ƒC“]w89%‚É‚ÍŸ‚Ä‚È‚¢‚ñ‚¾‚æwww

527:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:10:23.39 B93VS0CVa.net
‹ó”„‚èAM—p”ƒ‚¢Aƒtƒ@ƒ“ƒh”„‚肪ŒJ‚è•Ô‚·•‰‚̃XƒpƒCƒ‰ƒ‹‚©‚ËB
ÅI“I‚É‚ÍM—p”ƒ‚¢‚ªŒ¸‚é‚©ƒtƒ@ƒ“ƒ_Šî€‚ÌŠ”‰¿•Ó‚è‚ÅŽ~‚Ü‚éB
ƒoƒCƒI‚¾‚Æ‚»‚̊͓‚¢‚©‚çƒ`ƒLƒ“ƒŒ[ƒX‚ɂȂ肪‚¿‚©‚ÈB

528:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:13:14.21 iQwPD7nJV
ƒ}ƒCƒeƒ“‚ð‘_‚Á‚Ä‘å—Ê‚É”„‚èž‚ñ‚¾ƒnƒCƒJƒ‰‚͈ø‚¯‚Ü‚Å‚É”ƒ‚¢–ß‚³‚È‚¢‚Æ‚È‚ç‚È‚¢‚©‚ç‚È

529:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:19:36.56 fEAAUK/Dr.net
>>501
‚¨‚µ‚¢www
‚ ‚Æ1‰~‚Å‚Ü‚½Ž~‚Ü‚Á‚½www

530:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:29:33.09 iQwPD7nJV
ƒnƒCƒJƒ‰ƒoƒJƒ‹ƒT‚͉´’B‚Ìà•zBÎB

531:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:28:36.91 VJpuUSnId.net
>>491
Š”‰¿‘Îô‚Á‚ĉ½‚Å‚·H
ˆÀ‚¢‚Æ‚±‚ë‚Å•ªŠ„‚µ‚ĉº‚Ƀuƒb”ò‚΂·‚â‚‚ł·‚©H

532:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:34:39.74 iQwPD7nJV
ˆÀ’l‚Ńuƒb”ò‚΂³‚ꑱ‚¯‚é‹ó”„‚èƒoƒJƒtƒ@ƒ“ƒhBÎB

533:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:35:36.89 1MPffOi40.net
ƒAƒ‹ƒc‚Ì‚»[‚¹‚¢‚³‚ñA‚¶‚¥‚ñ‚¶‚¥‚ñオ‚ç‚Ë\‚ÈA‚¨‚¢B@ƒƒ‰ƒ^

534:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:43:56.19 iQwPD7nJV
‹ó”„‚èƒoƒJƒtƒ@ƒ“ƒh‚Í‘§‚µ‚Ä‚é‚Ì‚©H

535:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 10:45:16.91 iQwPD7nJV
‹ó”„‚èƒoƒJƒtƒ@ƒ“ƒh‚ª‚à‚¤”nŽ­‚È^Ž—‚µ‚È‚¢‚悤‚ÉuŽE‚·‚é‚悤‚È‚h‚q‚Ìo‚µ•û‚ðŒo‰cw‚É‚ÍŠè‚¢‚½‚¢‚ËB

536:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 11:00:48.11 /xv5eNRYa.net
>>498
ƒ‚ƒ‹ƒKƒ“—l‚Ì—Í‚¾‚æ

537:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 11:16:47.93 NWYXrTNd0.net
Ì‚Æ”ä‚ׂĕª‹ó”„‚è­‚È‚­‚È‚Á‚Ä‚é‚Ì‚È

538:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 11:30:33.36 iQwPD7nJV
ƒhƒCƒcØŒ”@ÅVƒŒ[ƒeƒBƒ“ƒOXV@buy 3500‰~

¢ŠE‚Í‘n–ò‹ó”„‚èƒtƒ@ƒ“ƒh‚É‚Æ‚Ç‚ß‚ðŽh‚¹‚ÆŒ¾‚Á‚Ä‚¢‚é
‚à‚¤Œã‚Í–³‚¢ƒs[ƒ^[“c‘º‚â‚é‚©‚â‚ç‚ê‚é‚©
“ŠŽ‘‰Æ‚Í“ñ—¬¤‹Æ‘呲‚É•‰‚¯‚éŽãŽÒ‚É—p‚Í–³‚¢
Žsê‚©‚ç‹Ž‚ê‚ÆŒ¾‚í‚ê‚Ä‚¢‚é‚Ì‚ª¡‚ÌŠ”‰¿‚¾‚ÆŽv‚¦
‚¢‚‚܂ő҂½‚¹‚é‹C‚¾H‚»‚ê‚Å‚àƒoƒCƒI‰¤‰Æ‚Ì––åá‚©I

539:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 11:31:10.65 ru+/ILlb0.net
’êŒÅ‚¢‚È

540:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 11:33:48.26 Bf3c85JQd.net
’ꂾ‚©‚ç‚È

541:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 11:38:47.67 1MPffOi40.net
‚Ç‚Ç[[[‚ñB

542:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:01:09.41 URGXItCRM.net
>>497
ãŽs‘҂‚¾‚¯‚ÅŽ‘ŽY””{‚¾‚©‚ç‚È

543:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:15:33.14 Kz1No6OZr.net
Ž¸”sŠm—¦‚ÍH

544:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:16:41.93 zaChqiXD0.net
ƒAƒ‹ƒc–ò‚ªŽ¸”s‚µ‚½‚玑ŽY”¼Œ¸

545:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:18:18.80 dq/WArGGp.net
ŒÜ–¡‚³‚ñ”ƒ‚¢‘‚µ‚ÌŽž‚µ‚©ã‚°‚Ä‚È‚¢‚Ì‚Å‚Í

546:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:19:22.32 zznfTj+6a.net
>>518
99.6ƒp[ƒZƒ“ƒg

547:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:20:43.16 URGXItCRM.net
ƒAƒ‹ƒc–ò‚¾‚¯‚¶‚á‚È‚¢‚©‚ç‚ÈB
>>518
SBI‚Í70%

548:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:31:26.54 iQwPD7nJV
¬Œ÷—¦30“‚ª‚P‚O–{‚ ‚ê‚΂R–{¬Œ÷‚¾‚©‚ç‚È
¬Œ÷‘O‚É‚R–{ãŽs‚


549:ðÜ‚èž‚Þ‚Ì‚ª¤•i‚Å‚Í‚È‚­Š”Ž®‚È‚Ì‚¾‚æ



550:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:35:08.39 zznfTj+6a.net
‚Í‚¢Aƒ}ƒC“]‚µ‚Ü[‚·w

551:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:35:57.65 Kz1No6OZr.net
‚¨‘Ò‚½‚¹ƒ}ƒCƒeƒ“

552:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:36:13.32 Rpy6I3if0.net
ƒ„ƒoƒC‚æAƒ„ƒoƒC‚æ

553:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:36:41.93 zznfTj+6a.net
ƒ‚ƒ‹ƒKƒ“—lâD’²I
ƒTƒ“ƒoƒCƒI‚Å‚à–\‚ê‚Ä‚¢‚Ü‚·I

554:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:36:55.60 1MPffOi40.net
‚ÜAƒ}A@ƒ}ƒC“_‚ł‚©HHH

555:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:38:58.99 Rpy6I3if0.net
ƒ}ƒC“]‚ÅŽQ‚Á‚Ä‚ñ‚È[

556:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:39:07.08 zaChqiXD0.net
ŒÜ–¡‚­‚¸–ˆ“úŽ‘ŽYŒ¸‚—‚—‚—‚—
‚­‚»‚¤‚¯‚é‚—‚—‚—‚—‚—‚—

557:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:41:30.84 iQwPD7nJV
”„‚èŒÍ‚ꃃƒ^

558:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:39:47.60 1MPffOi40.net
‚ @‚Ùƒ‹ƒ_[‚³‚ñA’¾–Ù’†I@ƒEƒP‚é‚£[

559:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:48:18.58 iQwPD7nJV
‚¢‚Á‚¹‚¢‚É“ª‹ó‚Á‚Ûƒ‚ƒOƒ‰‚ª”ò‚Ño‚µ‚Ä‚«‚½‚È‚—

560:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:57:38.38 Kz1No6OZr.net
ƒ}ƒCƒeƒ“‚¨‚ß‚Å‚Æ‚¤

561:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 12:58:41.85 zznfTj+6a.net
ƒ}ƒU[ƒY‚Ü‚¾‚Ü‚¾’´Š„‚‚炵‚¢‚Å
‚±‚ê‚©‚ç‘å–\—Ž‚ªŽn‚Ü‚é‚炵‚¢‚í

562:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 13:06:12.95 iQwPD7nJV
¡“ú‚̓‚ƒOƒ‰‚ª‚½‚­‚³‚ñ’@‚¯‚ÄŠy‚µ‚¢‚È

563:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 13:27:06.63 V9HarClld.net
ƒ}ƒC“]‚Í100%‚È‚¢

564:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 13:33:32.93 ru+/ILlb0.net
“S•Ç‚̌ł³‚¾‚È

565:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 13:38:57.32 3D5SNzRc0.net
“úŒo200‰~ˆÀ‚Å‚à‰º‚ª‚ç‚ñ‚È‚ 
‚Ç‚¤‚µ‚½H

566:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 13:40:43.09 V9HarClld.net
ƒ}ƒC“]‚·‚é‹C‚ª‚µ‚È‚¢

567:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:03:36.74 iQwPD7nJV
‚¨–~‹AÈ‚¨’f‚èI
‘Þêí‘àƒoƒJƒ‹ƒTƒ“‚u

568:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:03:15.08 BuCxj2sbr.net
2500Š”‚Ì”„‚蔂ðã‚Éo‚·ƒrƒr‚Á‚½ŒÂl‚ª‰º‚É“Š‚°‚é
ƒAƒ‹ƒS‚ª”„‚è‚𔃂Á‚ÄŒ³‚Ì’l‚É–ß‚·‚ðŒJ‚è•Ô‚µ‚Ä‚é‚Ë

569:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:10:47.41 ZhxjsC2Ix.net
ŒÜ–¡‚³‚ñ‚Ç‚¤‚È‚é‚ÌH

570:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:14:33.24 1MPffOi40.net
¡“úÅ‘å‚ÌŒ©‚Ç‚±‚ë‚ÍA
ƒAƒ‹ƒc‚Ì‚»[‚¹‚¢‚³‚ñ‚ªAŠÑ˜^‚Ì‚U“ú‘±—Ž‚·‚é‚©‚Ç‚¤‚©‚ªŒ©‚à‚ÌB

571:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:21:11.30 1MPffOi40.net
‚¨‚Á‚ÆA•Ï‚í‚炸‚ªˆê“ú‚ ‚Á‚½‚©‚çA
¡“ú‰º‚ª‚ê‚Ίј^‚Ì‚T“ú‘±—Ž‚Æ‚È‚éB

572:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:29:58.43 /xv5eNRYa.net
â‘΃vƒ‰“]‚Í‹–‚³‚ê‚È‚¢‚©‚ç‘åä•vI
ƒ‚ƒ‹ƒKƒ“är‚ß‚½‚ç‚ ‚©‚ñ‚¼

573:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:34:13.48 /xv5eNRYa.net
ˆÀ’lˆø‚¯ƒƒbƒNƒIƒ“II

574:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:34:43.87 LZDZT36h0.net
‚»[‚¹‚¢Š”Žå‚Í‘Sˆõ•æê‚És‚­‚ñ‚¾‚æ
’Nˆêl—˜‰vo‚³‚¹‚Ë‚¦‚æ

575:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:34:55.49 XowckZ8R0.net
¡“ú‚à”N‰ˆÀ’lXV‚©H

576:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:35:16.54 XowckZ8R0.net
ˆê‹C‚É‚Ô‚ñ“Š‚°‚ăƒƒ^

577:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:35:26.86 /xv5eNRYa.net
‚«‚½[II
‚³‚·‚ªƒ‚ƒ‹ƒKƒ“—l

578:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:35:32.72 ru+/ILlb0.net
‚¨‚¢‚¨‚¢Å‘¬“`à‚«‚Ä‚é

579:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:35:34.54 LZDZT36h0.net
‚»[‚¹‚¢Š”Žå‚Í‘Sˆõ•æê
‚¾‚©‚甄‚ê‚Á‚Ä—]—T‚¾‚©‚çâ‘Îオ‚ç‚È‚¢
â‘Îオ‚ç‚È‚¢

580:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:36:03.06 ru+/ILlb0.net
–û’f‚µ‚½ ‚É‚±‚ê
‚¨–~‚¾‚낤‚ƈê“ú‚½‚è‚Æ‚à‹x‚Ü‚¹‚È‚¢‚È

581:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:36:30.74 /xv5eNRYa.net
ƒ‚ƒ‹ƒKƒ“—l‚Ì“Æ’dê

582:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:39:53.19 GZ68lGH50.net
À‚­‚£

583:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:43:04.66 JI8Cij+qM.net
ƒs[ƒ^[‚̓oƒJƒ“ƒX’†‚Ä‚·‚©H

584:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:43:37.93 VJpuUSnId.net
Œo‰cw‚Æ”ƒ‚¢ø‚è‚ÍŽ€‚ñ‚Řl‚Ñ‚ë
‹ó”„‚è‚ÍŽ€‚ñ‚Ç‚¯

585:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:48:01.95 iQwPD7nJV
’N‚àƒnƒCƒJƒ‰‚ðŒ©‚¹‚ç‚ê‚È‚¢‘Þêƒoƒ`ƒƒƒ‹ƒTBÎB

586:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:50:29.40 iQwPD7nJV
‰º‚ª‚é‚ÆŽv‚Á‚½’ö“x‚Å‚æ‚­Šì‚ׂéBÎB

587:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:55:36.16 ileX3GJad.net
³‚É’ê‚È‚µB3Œ…s‚Á‚Ä‚Ü‚¤‚Ì‚©‚±‚êB

588:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:57:25.23 /xv5eNRYa.net
¡”NÞ—¿–³‚µ‚Á‚ĉïŽÐ‚ªŒöŽ®‚É”­•\‚µ‚Ä‚é‚©‚çA‹ó”„‚è‚â‚肽‚¢•ú‘肾‚æ
‹ó”„‚è‘S‚­•|‚­–³‚¢‚à‚ñ‚È
Š”‰¿Ž©—RŽ©Ý‚ɉº‚°‚ê‚é‚æ

589:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 14:59:05.43 CjYuEkvrr.net
‹ó”„‚肶‚á‚È‚­‚Ä‚ ƒzƒ‹ƒ_[‚Ì‚¨‘O‚炪ƒoƒPƒcƒŠƒŒ[‚µ‚Ä‚é‚ñ‚¾‚ëwww
‚’l‚Å”ƒ‚Á‚Ä‚½‚â‚‚ª’ÇØ‚É“Š‚°‚»‚¤‚¾‚©‚Í“Š‚°‚ÄA¡“ú”ƒ‚Á‚½‚â‚‚Í1000‰~‚Å’ÇØ“Š‚°
‚»‚ê‚ÌŒJ‚è•Ô‚µ

590:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:02:18.80


591:iQwPD7nJV



592:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:01:07.11 /xv5eNRYa.net
¡“ú‚à‹ó”„‚èŠOŽ‘‚Ìâ‘Îã‚°‚³‚¹‚È‚¢‚Æ‚¢‚¤‹­‚¢ˆÓŽu‚ðŠ´‚¶‚½“à—e‚¾‚Á‚½B
–¾“ú‚͈ê‹C‚É3Œ…‘_‚¦‚»‚¤‚¾

593:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:01:09.89 Ne5TXfvb0.net
˜A“úA–{“–‚É•³‚Ý‚Ä‚¦‚ɉº‚ª‚é‚È

594:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:03:54.33 1MPffOi40.net
‚ @‚Ùƒ‹ƒ_[‚³‚ñA‰V‚Å‚àH‚ׂČ³‹C‚¾‚µ‚È‚æB@

595:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:03:56.02 V9HarClld.net
ƒNƒ\Š”‚¾‚©‚ç‚È

596:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:07:23.32 iQwPD7nJV
‚l‚t‚e‚f‚ª”ƒ‚¢–ß‚³‚È‚©‚Á‚½Ž–‚͉ߋŽ‚Í–³‚¢‚©‚ç‚Ë
­‚µ‘҂Ă΂V‚W–œŠ”‚Ì”ƒ‚¢‚ª—ˆ‚é‚Å‚µ‚å

597:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:06:17.97 ru+/ILlb0.net
12ƒ–ŒŽ˜A‘±‰º—Ž‚à–ÚŽw‚¹‚é‚È
‰º‚°•Žc‚µ‚‚ÂãŽè‚¢‚±‚Æ‚â‚Á‚Ä‚é‚í

598:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:07:28.38 CjYuEkvrr.net
ƒQ[ƒ€Š”’S•Û‚É‚»[‚¹‚¢”ƒ‚Á‚Ä‚é‚â‚Â
‚»[‚¹‚¢’S•Û‚Ƀƒ‹ƒJƒŠ”ƒ‚Á‚Ä‚é‚â‚Â
‚»[‚¹‚¢”ƒ‚Á‚Ä‚é‚Ù‚Æ‚ñ‚Ç‚ÌlŠÔ‚͈ꕔ‚Ì‚»[‚¹‚¢MŽÒ‚ƈá‚Á‚ÄŠy‚µ‚Ä‚¨‹àŽ‚¿‚ɂȂ肽‚¢lŠÔ‚¾‚©‚çV‹»‚ðM—p‚Å”ƒ‚Á‚Ä‚é
‘¼‚Ì–Á•¿‚ª‰º‚°‚é‚Æ’Ç؉ñ”ð‚Ì“Š‚°‚ªo‚é‚©‚牄X‚ɉº‚°‚é‚æwww
Œ«‚¢‚»[‚¹‚¢MŽÒ‚ª”ƒ‚¢ø‚肵‚Ä‚à‚Ù‚Æ‚ñ‚ǂ̃zƒ‹ƒ_[‚͈ꔭ‘_‚¢‚̃_ƒlŠÔ‚È‚ñ‚¾‚©‚ç
‚±‚ñ‚ȈÀ’l‚Å”„‚é‚È‚Æà–¾‚µ‚Ä‚à–³‘Ê–³‘Ê–³‘Ê`

599:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:13:45.88 tpYXh8rP0.net
ƒJƒLƒR‚µ‚Ă锃‚¢•û‚ÍA‚¢‚­‚ç‚ʼn½–‡‚­‚ç‚¢‚È‚ÌH

600:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:18:39.88 iQwPD7nJV
‚»‚Ì’ö“x‚ÌŠ”‚É‚R‚U‚T“ú’©‚©‚ç”Ó‚Ü‚Å”„‚èø‚肪”S’…‚·‚é‚ÆŽv‚¤‚©H
’Ê팈ŽZ‚¾‚¯‚ŃAƒNƒ‰ƒ“‚RˆÊB
‚Ü‚½“ú–{ˆê‚Ì’lオ‚è‚ð‚·‚é‚Æ“Ç‚ñ‚Å‚é˜A’†‚ªƒEƒWƒƒƒEƒWƒƒ‚¢‚é‚©‚炾‚ë
Žs‹µ‚P‚ÉŒfŽ¦”‚ªŽc‚Á‚Ä‚é‚Ì‚à‚±‚±‚Æ”‚¦‚é‚®‚ç‚¢’–Ú‚³‚ê‚Ä‚¢‚é

601:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:32:49.49 CfoVyQNc0.net
26000‚ÅŒ‹\Žd“ü‚ꂽ

602:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:34:20.53 iQwPD7nJV
‚Ç‚¤‚â‚Á‚½‚犔‚ňê”ÔŒø—¦‚æ‚­Ÿ‚Ä‚éH
”ƒ‚Á‚Ä‚él‚Æ“¯‚¶Ž–‚ª‚Å‚«‚ê‚ÎA‚»‚ꂪˆê”Ô‹ß“¹‚¾‚à‚ñ‚ÈB

603:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:33:31.23 pKo5FLyq0.net
ƒNƒ\

604:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:34:27.90 b4EKzWIpa.net
ƒtƒNƒƒE‚ª‚»[‚¹‚¢‚ÉŠyŠÏ“I
ƒ}ƒU[ƒY’ê‘Å‚¿éŒ¾‚Ü‚Å

605:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:45:07.32 ZtjEaDblM.net
1–‡‚¾‚¯
3”NŽ‚Á‚Ä‚é

606:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:55:09.94 +wkOLpER0.net
ˆÀ‚­”ƒ‚¦‚邱‚Æ‚ÉŠ´ŽÓ‚µ‚悤

607:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 15:55:41.28 V9HarClld.net
ƒtƒEƒƒE‚Å’N‚¾‚æw wwwwwww

608:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 16:09:09.14 rcWMFyqj0.net
ŒÜ–¡‚̃Sƒ~ƒiƒ“ƒsƒ“ŽŸ‚¢‚­‚炾H‚Í‚æŒvŽZ‚µ‚ëI

609:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 16:16:13.26 /xv5eNRYa.net
ƒ‚ƒ‹ƒKƒ“‚É‚Æ‚ñ‚Å‚à‚È‚¢ˆ«Þ—¿˜R‚ê‚Ä‚é‚ñ‚Æ‚¿‚Ⴄ‚©H

610:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:00:26.68 CizuQsNQ0.net
ŽŸ‚È‚é”ò–ô‚ÖB’…ŽÀ‚Èi’»‚Æ‹¤‚ÉX‚Ȃ鬒·‚Ìêt–¾Šú‚É‚ÄU‚é‚¢ˆç‚¿‚ä‚­‘ŠêBT‚¦‚éÞ—¿‚Æ‹¤‚É…€’ù³BÎB
¬’·ŠúB—\’肳‚ê‚Ä‚¢‚½‹ÆÑ‚Ì‹}¬’·‚Æ‹¤‚ÉX‚Ȃ鬒·í—ª‚ªi“WB‡’²‚ÈR&DEPL“™‚ÌŠg[EŠg‘å‚̉Á‘¬BÎB
Heptares is based the New Research Facility (Steinmetz Building) of Granta Park (Cambridge) from August 2018.
EEE
¦SOSEIŠ”Žå’ÊMFu“ú–{‰‚Ì‘Û“I‚ȃŠ[ƒfƒBƒ“ƒOƒoƒCƒI»–òŠé‹Æ‚ð–ÚŽw‚µ‚ÄvF“–ŽÐ‚Í‘å‚«‚Ȭ’·‚ð‹‚°A“ú–{‰‚Ì‘Û“I‚ȃŠ[ƒfƒBƒ“ƒOƒoƒCƒI»–òŠé‹Æ‚Ö‚Ì“¹‚ð‡’²‚Éi‚ñ‚Å‚¢‚Ü‚·B2018”N3ŒŽŠú‚Í‚±‚ê‚Ü‚Å‚ÅÅ‚à‘å‚«‚Èi•à‚ð‹‚°‚½”N‚É‚È‚è‚Ü‚µ‚½B(8/6)
¦ŒÂ•ÊŠ”î•ñFSBIØŒ”‚Å‚ÍAHeptaresŠJ”­ƒpƒCƒvƒ‰ƒ“‚Ì’†’·Šú“I‚ÈŽ¡Œ±‚Ìi‚¿‚å‚­‚ÉŠú‘ÒB“¯ŽÐ‚ÌŽ–‹Æ‰¿’l‚ÍHeptares‚ÌŠJ”­ƒpƒCƒvƒ‰ƒCƒ“‚É‚ÄŒˆ‚Ü‚éB‚±‚ÌŠ”‰¿…€‚ÍAHeptaresƒpƒCƒvƒ‰ƒCƒ“‚ªŠJ”­‘O”¼í‚Å‚ ‚邱‚Æ‚ð‰Á–¡‚·‚é‚Æu“K³v‰¿Ši‚É


611:—Ž‚¿’…‚¢‚Ä‚¢‚éB(8/6) ¦Heptares Twitter (Change Name): Heptares¨hSosei Heptaresh. (8/6 Changed) ¦‚ ‚·‚©»–ò •½¬31”N3ŒŽŠú‘æ1Žl”¼ŠúŒˆŽZFŽå—Í•i‚Ì”„ã‚F‹Ù‹}”ð”DÜ(ƒmƒ‹ƒŒƒ{)F“–Šú‘æ1Žl”¼Šú3.1‰­‰~(‘OŠú‘æ1Žl”¼Šú3.2‰­‰~)A‘ΑO”N“¯Žl”¼Šú‘Œ¸—¦¢1.6“A“–Šú”NŠÔŒ©ž12.6‰­‰~(‘OŠú”NŠÔŽÀÑ12.1‰­‰~) (8/6) ¦Medicinal Chemistry GRC: "Novel Adenosine 2A Receptor Antagonist AZD4635: From the Brain to the Tumor Microenvironment": Michelle Lamb, AstraZeneca USA. (8/6 Presented) ¦Oligonucleotide Therapeutics Society (OTS): The newest Paper of the Month is Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer. (8/6) ¦‰¢B“Á‹–(Sosei R&D)FTreatment of Respiratory Diseases. (8/8ŒöŠJ) ¦Pluristem Initiates Two Pivotal Phase III Studies in Israel. Numerous Clinical Sites in Israel to join sites in the U.S. and Europe for Pivotal Phase III Studies of PLX-PAD Cell Therapy in the Treatment of Critical Limb Ischemia and Muscle Injury Following Hip Fracture. (8/8) ¦SOSEI 2018”N12ŒŽŠú‘æ1Žl”¼ŠúŒˆŽZFŒ¤‹†ŠJ”­”ï1,826•S–œ‰~(69.5“‘‰Á) 97.3%‚͉p‘Šˆ“®Bƒvƒ‰ƒbƒgƒtƒH[ƒ€‚ðˆø‚«‘±‚«Šg[B“–ŽÐƒOƒ‹[ƒv‚Í13•i–Ú‚ª‘n–ò’iŠKA5•i–Ú‚ª‘O—Õ°ŽŽŒ±’†A4•i–Ú(ƒŒƒr[¬‘ÌŒ^”F’mÇ(DLB)Š³ŽÒ‚ð‘ÎÛ‚Æ‚µ‚½“ú–{‚É‚¨‚¯‚é‘OŠú‘æ‡U‘ŠŽŽŒ±‚ðŠÜ‚Þ)‚ª—Õ°ŽŽŒ±’†B(8/9) ¦ƒyƒvƒ`ƒhƒŠ[ƒ€ •½¬30”N6ŒŽŠúŒˆŽZFPAR2‚ɑ΂µA‚‚¢e˜a«‚Æ‘I‘ð«‚ð—L‚·‚éƒyƒvƒ`ƒhEƒAƒ“ƒ^ƒSƒjƒXƒg‚𓯒肵‚Ä‚¨‚èA‚±‚̃vƒƒOƒ‰ƒ€‚ÍŒ»ÝAHit-to-Lead‚̃Xƒe[ƒW‚É“ü‚Á‚Ä‚¨‚è‚Ü‚·B(8/9) ¦JITSUBOF“–ŽÐ‹Zp‚ÉŠÖ˜A‚·‚é˜_•¶‚ð’ljÁ‚µ‚Ü‚µ‚½BˆÈ‰º(“–ŽÐ‹ZpŠÖ˜A˜_•¶ƒy[ƒW)‚æ‚育Šm”F‚­‚¾‚³‚¢B(8/9) ¦•Ä‘“Á‹–oŠè(Heptares)FMuscarinic Agonists. (8/9ŒöŠJ) ¦ClinicalTrials(NCT03592862: HTL0018318-203): Phase 2, A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies (DLB). Locations(Add, Study Research Site): Kurumi Clinic(‚­‚é‚݃NƒŠƒjƒbƒN): "Recruiting", Tokyo, Japan. (8/9update.) ¦ƒAƒCƒtƒBƒXŠ”—\•ñF“úŒn‘åŽèØŒ”(‚Ý‚¸‚ÙØŒ”)A‚»[‚¹‚¢ƒŒ[ƒeƒBƒ“ƒO‹­‹C(”ƒ‚¢)Œp‘±B–Ú•WŠ”‰¿21,600‰~(5/18)¨5,400‰~B–Ú•WŠ”‰¿ƒRƒ“ƒZƒ“ƒTƒX‚Í3,278‰~(ƒAƒiƒŠƒXƒg”8l)B(8/9) ¦ƒAƒCƒtƒBƒXŠ”—\•ñF2018”N12ŒŽŠú ‹ÆÑ—\‘zƒRƒ“ƒZƒ“ƒTƒX(8/10XV) ¦ReutersFSOSEI 2018-2022‹ÆÑ—\‘zƒRƒ“ƒZƒ“ƒTƒXB(8/10update) ¦Žl‹G•ñƒIƒ“ƒ‰ƒCƒ“Fˆã–ò¥ƒoƒCƒIƒxƒ“ƒ`ƒƒ[‚Ì•]‰¿‚ʼn½‚ªd—v‚©B‰Ÿ‚¦‚Ä‚¨‚­‚ׂ«3‚‚̃|ƒCƒ“ƒgB‚»[‚¹‚¢ƒOƒ‹[ƒvFˆêŽž‹à‚Ì”—ŽŒã‚Í‹ÆÑ‚ª’á–ÀBŠé‹Æ”ƒŽû‚ɑ΂·‚é–Ú—˜‚«—Í‚Í‚‚­•]‰¿‚³‚ꂽ‚à‚Ì‚ÌA“ÆŽ©ŠJ”­‚Í‚±‚ê‚©‚çA¡ŒãA–{“–‚̈Ӗ¡‚Å‚ÌŠJ”­—Í‚ª–â‚í‚ê‚é‹Ç–Ê‚É“ü‚Á‚Ä‚¢‚­B(8/13) ¦ClinicalTrials(NCT03592862: HTL0018318-203): Phase 2, A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies (DLB). Change Study Status: Not yet Recruiting¨"Recruiting". (8/13update.) ¦Vaccinex: Form 10-Q(SEC Filings): hCollaboration Agreements: hIn June 2018, the Company entered into a research service agreement with Heptares Therapeutics, Ltd. to provide research services to Heptares. (8/14)



612:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:00:48.60 CizuQsNQ0.net
¦ƒƒ‹ƒgƒŒF‚»[‚¹‚¢“ŠŽ‘æsƒoƒCƒIŠé‹ÆAƒŒƒr[¬‘ÌŒ^”F’mÇ—Õ°ŽŽŒ±‚É’–ÚB(8/15)
[”F’mÇŽ¡—Öò‚Ì—Õ°ŽŽŒ±ŠJŽn‚ªŠ”‰¿Þ—¿]
E‚»[‚¹‚¢ƒOƒ‹[ƒvŠ”‰¿‚ª•ªŠ„Œã‚Ìãê—ˆˆÀ’l‚ðXVAŒßŒã2Žž35•ª‚É‘O“ú”ä32‰~ˆÀ‚Ì1205‰~‚Ü‚Å”„‚ç‚ê‚éê–Ê‚ª‚ ‚Á‚½B
Eƒ}ƒU[ƒYŽw”‚̉º—Ž‚ªŽs‹µƒjƒ…[ƒX‚Řb‘è‚É‚È‚é‚È‚©AŠ”‰¿ƒpƒtƒH[ƒ}ƒ“ƒX‚̈«‚¢ƒoƒCƒIŠ”‚ðŽè•ú‚·“®‚«‚ªo‚Ä‚¢‚é–Í—lB
EV‹»Žsê‚̃oƒCƒIŠé‹Æ‚ÌŠ”‰¿‚Í‘‚¶‚Ä“î’²Aƒ\ƒŒƒCƒWƒAEƒtƒ@[ƒ}(4597)‚Í8ŒŽ13“ú‚É221‰~‚܂ʼnº—Ž‚µ‚Ä”N‰—ˆˆÀ’l‚ð‹L˜^Aƒyƒvƒ`ƒhƒŠ[ƒ€(4587)‚Í8ŒŽ15“ú‘Oê‚É3625‰~‚܂ʼnº—Ž‚µ‚Ä”N‰—ˆˆÀ’l‚ð‹L˜^‚µ‚½B
E‚Ý‚¸‚ÙØŒ”‚Í‚»[‚¹‚¢ƒOƒ‹[ƒvŒ©’Ê‚µ‚ɂ‚¢‚ÄAHTL18318‚̃Œƒr[¬‘ÌŒ^”F’mÇ‚Ì‘“àPhase2ŽŽŒ±‚ªŠÔ‚à‚È‚­ŠJŽn‚³‚ê‚é‚Æ‚Ìl‚¦‚É•ÏX‚ª–³‚¢‚ƃŒƒ|[ƒg‚ʼnðà‚µ‚Ä‚¢‚éB
E‚Ü‚½8ŒŽ9“ú‚É2019”N4ŒŽ`6ŒŽŠúŒˆŽZ”­•\‚ÍŒ¤‹†ŠJ”­“ŠŽ‘æs‚̃oƒCƒIŠé‹Æ‚Å‚ ‚茈ŽZ‚ɃTƒvƒ‰ƒCƒY‚Í‚È‚­AƒoƒCƒIŠé‹Æ‚ð‘«Œ³‚Ì‹ÆÑ‚Å”»’f‚·‚é‚Ì‚Í“KØ‚Å‚Í‚È‚¢‚Æ‚àà–¾‚µ‚Ä‚¢‚éB
E‚¢‚¸‚ê‚É‚¹‚æ–Úæ‚ÌŠ”‰¿‚ÍŒµ‚µ‚¢‹Ç–Ê‚¾‚ªA8ŒŽ‚É—Õ°ŽŽŒ±ŠJŽn‚ª”­•\‚³‚ꂽ‚ç’²®‚µ‚Ä‚½Š”‰¿”½”­‚ÌÞ—¿‚Æ’–Ú‚³‚ê‚»‚¤B
URLØݸ(merutore.com)
¦ƒtƒBƒXƒRFŒÂl“ŠŽ‘‰ÆŠ”ŽtE–¾F2018”Nƒm[ƒxƒ‹ÜŒó•â‚©‚ç˜A‘z‚³‚ê‚éƒm[ƒxƒ‹ÜŠÖ˜A–Á•¿‚Æ‚ÍHyFISCOƒ\[ƒVƒƒƒ‹ƒŒƒ|[ƒ^[z(8/15 13:08)
Eƒm[ƒxƒ‹Ü‚ÍA–ˆ”NH‚ÉŽóÜŽÒ‚ª”­•\‚³‚ê‚邪A‹ß”N‚Í‚Æ‚­‚ÉŽóÜŽÒ”­•\‚ÌŽžŠú‚ª‹ß‚­‚ɂ‚ê‚ÄAŽóÜŽÒ‚Ì—\‘z‚ªŠˆ”­‰»‚·‚éB
E‚à‚¿‚ë‚ñŠ”Ž®Žsê‚Å‚àAƒm[ƒxƒ‹ÜŒó•âŽÒ‚ÌŒ¤‹†‚ÉŠÖ˜A‚·‚é–Á•¿‚Ö‚ÌŽ‘‹à—¬“ü‚ªŠú‘Ò‚Å‚«‚éB
E‹ß”N‚Í“ú–{lŽóÜŽÒ‚ªo‚éƒP[ƒX‚à‘½‚¢‚½‚ß‘“à‚Å‚àƒm[ƒxƒ‹Ü‚Ö‚Ì’–Ú“x‚Í‚‚­A‰Ä‚Ì‚¤‚¿‚©‚çƒm[ƒxƒ‹ÜŠÖ˜A–Á•¿‚ª“ö‚í‚¢Žn‚߂邱‚Æ‚à‚ ‚蓾‚éB
ƒm[ƒxƒ‹ÜŠÖ˜A–Á•¿F‚»[‚¹‚¢ƒOƒ‹[ƒvF
EƒoƒCƒIƒxƒ“ƒ`ƒƒ[‚Æ‚µ‚Ä“ŒØƒ}ƒU[ƒYŽsê‚Å‘å‚«‚È‘¶ÝŠ´‚ðŽ¦‚µ‚Ä‚¢‚éB
EŒ¤‹†ŠJ”­‚É—Í‚ð“ü‚ê‚邪‚ñŽ¡—Öò‚È‚Ç‚ÉŠÖ˜A‚·‚錤‹†‚ªƒm[ƒxƒ‹Ü‚ðŽóÜ‚·‚ê‚ÎA‘‚È‚Ç‚É‚æ‚éŒã‰Ÿ‚µ‚ÉŠú‘Ò‚µ‚â‚·‚­‚È‚éB
E“ú–{l‚ªŽó܂𓦂µ‚½ê‡‚Å‚àAŽó܃e[ƒ}ŽŸ‘æ‚Å’–Ú“xƒAƒbƒv‚̃`ƒƒƒ“ƒX‚ª‚ ‚é–Á•¿‚¾‚낤B
‘Š‡F
E“ú–{l‚É‚à‘½”‚ÌŽóÜŒó•âŽÒ‚ª‘¶Ý‚µAŽó܃e[ƒ}‚ÆŠÖ˜A‚·‚錤‹†‚ÉŽæ‚è‘g‚Þ–Á•¿‚ª•¨F‘ÎÛ‚Æ‚È‚è‚â‚·‚¢B
E‰¼‚Ƀm[ƒxƒ‹Ü‚ÌŽó܃e[ƒ}‚Æ‚È‚ç‚È‚©‚Á‚½ê‡‚Å‚à¡Œã‚̬’·‚ÉŠú‘Ò‚Å‚«‚錤‹†‚ÉŽæ‚è‘g‚Þ–Á•¿‚ªŠÖ˜A–Á•¿‚Ì’†S‚Æ‚È‚Á‚Ä‚¨‚èAæ‰ñ‚肵‚Ä”ƒ‚¢‚ð“ü‚ê‚Ä‚Ý‚Ä‚à‚æ‚¢‚¾‚낤B
E‚¢‚¸‚ê‚É‚¹‚æA‘‚¢’iŠK‚Å‚Ç‚ñ‚È–Á•¿‚ª‘ÎۂƂȂ肤‚é‚Ì‚©‚Í‚µ‚Á‚©‚è‚Æ”cˆ¬‚µ‚Ä‚¨‚­‚ׂ«‚¾B
EEE

613:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:02:00.39 CizuQsNQ0.net
¦SOSEI‚̬’·‘Šê‚Ì“®ŒüF[Š”Ž®4•ªŠ„F(6/27)•ªŠ„”ä—¦C³Ï]
2014/_4/25 (I’l_515) ”„Žc‚144800 ”ƒŽc‚_4212800 E(2014/_4/22ňÀ’l_464)¦[¬’·‰ñŽûŠú‚Ì“üŒû]ƒXƒe[ƒW‚Ö
201


614:5/_2/20 (I’l_945) ”„Žc‚_56800 ”ƒŽc‚_6123200 E(2015/_3/16ňÀ’l_713)¦Heptares [¬Œ÷‚̘̓Xƒe[ƒW] 2015/10/30 (I’l1080) ”„Žc‚_45600 ”ƒŽc‚_8871600 E(2015/_9/24ˆÀ’l_888)¦•Ä‘³”F[ŽŸ‚È‚é”ò–ôƒXƒe[ƒW‚Ö]¦[㔲‚¯Œ—‚Ö] 2016/_4/25 (I’l5808) ”„Žc‚159200 ”ƒŽc‚13619600 E(2016_5/_9Å‚’l6545)¦Allergan[‹­‹C‘Šê] 2016/_6/24 (I’l3680) ”„Žc‚_42000 ”ƒŽc‚_9944400 E(2016/_6/24ˆÀ’l3240)¦[‹­‹C‘Šê‰ðœ]¦[ŽžŠÔŽ²‚Å‚Ì’²®‹Ç–Ê‚Ö] 2017/_3/31 (I’l2720) ”„Žc‚_22400 ”ƒŽc‚10487200 E(2017/_4/_4ˆÀ’l2570)¦[ŽžŠÔŽ²’²®‚͇’²‚É„ˆÚ]¦[U‚é‚¢êEE‚¢ê‚Ö] 2017/_9/_8 (I’l2175) ”„Žc‚__7600 ”ƒŽc‚_8151200 E(2017/_9/_6ňÀ’l2147)¦[E‚¢ê‚à‡’²‚É„ˆÚ] 2018/_1/26 (I’l3053) ”„Žc‚__3600 ”ƒŽc‚_5716400 E(1/22ˆÀ’l2740)¦[U‚é‚¢‚à‡’²‚É„ˆÚ] 2018/_3/_9 (I’l2378) ”„Žc‚_42000 ”ƒŽc‚_7177600 E(3/_5ˆÀ’l2195)¦[ˆ«’n‡‚¢‚É‚ÄÄ‚Ñ‚ÌE‚¢ê‚Ö] 2018/_6/29 (I’l1784) ”„Žc‚_____0 ”ƒŽc‚_7931600 E(6/20ˆÀ’l1595) ¦‹ó”„‚艿Ši‹K§ƒgƒŠƒK[(5/11ˆÀ’l1665, 6/5ˆÀ’l1695) 2018/_7/_6 (I’l1387) ”„Žc‚__7300 ”ƒŽc‚_7728300 E(7/_5ˆÀ’l1304) ¦‹ó”„‚艿Ši‹K§ƒgƒŠƒK[(7/2ˆÀ’l1584, 7/3ˆÀ’l1414) 2018/_7/13 (I’l1412) ”„Žc‚__6800 ”ƒŽc‚_7479600 E(7/11ˆÀ’l1342) 2018/_7/20 (I’l1329) ”„Žc‚_10700 ”ƒŽc‚_7489500 E(7/20ˆÀ’l1308) 2018/_7/27 (I’l1422) ”„Žc‚__6600 ”ƒŽc‚_7579800 E(7/23ˆÀ’l1325) 2018/_8/_3 (I’l1369) ”„Žc‚__6600 ”ƒŽc‚_7358300(-221500) E(8/_2ˆÀ’l1366) 2018/_8/10 (I’l1369) ”„Žc‚__6600 ”ƒŽc‚_7101500(-256800)¦8/14up E(8/8ˆÀ’l1366) 2018/_8/13 (I’l1255) 5“úü˜¨—£(-7.31“) 25“úü˜¨—£(_-9.09“) 75“úü˜¨—£(-23.02“) 200“úü˜¨—£(-42.92“) (ˆÀ’l1250) 2018/_8/14 (I’l1237) 5“úü˜¨—£(-6.30“) 25“úü˜¨—£(_-9.94“) 75“úü˜¨—£(-23.76“) 200“úü˜¨—£(-43.58“) (ˆÀ’l1213) 2018/_8/15 (I’l1225) 5“úü˜¨—£(-5.11“) 25“úü˜¨—£(-10.32“) 75“úü˜¨—£(-24.08“) 200“úü˜¨—£(-43.96“) (ňÀ’l1205)¦[”N‰—ˆˆÀ’lXV] X‚Ȃ鬒·‚Ìêt–¾Šú‚É‚ÄA‹­‹C‘ŠêŒã‚ÌŽžŠÔŽ²‚Å‚Ì’²®I”Ղ͇’²‚É„ˆÚBÎB ¬’·í—ª‚à‡’²E’…ŽÀ‚Èi“W‚ÅAŽŸ‚È‚é“WŠJEi’»‚ªŠy‚µ‚Ý‚Å‚·‚ËBÎB



615:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:19:10.85 iQwPD7nJV
>>583
ŒÃ‚¢‚¢‚ç‚ñ
>>584
‘f°‚炵‚¢
>>585
“\‚éˆÓ–¡

616:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:19:23.44 J4ulHTger.net
–{“–‚É8ŒŽ‚ÉŠJŽn‚·‚é‚ÌH
‚à‚¤8ŒŽ‚àŒã”¼‚É“ü‚é‚ñ‚¾‚ª

617:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:24:52.53 iQwPD7nJV
Gƒ^ƒ“ƒpƒN‹¤–ðŽó—e‘Ì(GPCR)@2012”N
ƒNƒ‰ƒCƒI“dŽqŒ°”÷‹¾@2017”N
‚ªƒm[ƒxƒ‹Ü‚ðŽóÜ
‚Ç‚¿‚ç‚à‚»[‚¹‚¢‚Ç^‚ñ’†
¡”N‚à‰½‚©”ò‚Ño‚µ‚»‚¤‚ÈŽv˜f‚Í‚¶‚イ‚Ô‚ñ‚Å‚·‚Ë

618:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:36:49.12 1MPffOi40.net
‚Ç[[[‚ñB

619:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:37:34.29 29xzNqYN0.net
¡“ú‚©‚甃‚¢Žn‚ß‚½A‘‘¬ŠÜ‚Ý‘¹B

620:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:39:10.99 /xv5eNRYa.net
>>587
ŠJŽn‚µ‚½‚Æ‚±‚ë‚ÅD‚èž‚ÝÏ‚Ý‚¾‚µA‚à‚µã‚ª‚é‚悤‚È‚ç‘å—ʋ󔄂肳‚ê‚ÄA‹t‚É‘å–\—Ž‚·‚é‚æB

621:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:43:02.88 /xv5eNRYa.net
‹ó”„‚èÕ‚èŠJÃ’†II
‘Ü’@‚«ó‘ÔII
2018”N08ŒŽ
13“ú Credit Suisse Securities
0.780% +0.140% +107,300
596,032Š”
(0.780%)
13“ú AQR Capital Management
0.490% ÄIN
377,400Š”
(0.490%)
13“ú ƒ‚ƒ‹ƒKƒ“EƒXƒ^ƒ“ƒŒ[MUFG
1.020% +0.210% +164,500

622:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 17:49:58.20 VJpuUSnId.net
‚æ‚­‚à‚±‚±‚Ü‚ÅŠ”‰¿šÊ‘¹‚µ‚Ä‚­‚ꂽ‚È
‚¢‚¸‚ê–½‚ðˆÈ‚Á‚Ä—Ž‚Æ‚µ‘O•t‚¯‚³‚¹‚½‚é‚©‚çŠoŒå‚¹‚¥‚æ

623:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 18:07:10.52 iQwPD7nJV
”„‚èŽc‚P“‚µ‚å‚Ú‚·‚¬ƒƒƒ^‚—
”ƒ‚¢‚Í‚T“ˆÈ‰º‚È‚ñ‚Ä–¼‘O‚àŒÄ‚΂ê‚Ë‚¦‚æB

624:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 18:12:08.50 2OQQP2Php.net
–½‚¶‚á’ނ臂¢Žæ‚ê‚ñƒŒƒxƒ‹‚¶‚Ⴏ‚¦‚Ì‚¤

625:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 18:24:46.53 iQwPD7nJV
‚»‚à‚»‚à26000‰~‚Å”ƒ‚Á‚½‚æ‚Ý‚½‚¢‚É
1200‰~‚Å100–œŠ””„‚Á‚½‚æ‚Á‚ÄŒ¾‚í‚ê‚Ä‚àAŠJ‚¢‚½Œû‚ª‚Ó‚³‚ª‚ç‚È‚¢B
“ª‘åä•vH‚ ‚ñ‚½Ž€‚Ê‚í‚æB‚Æ‚µ‚©Œ¾‚¢‚悤‚ª–³‚¢‚¾‚ëBÎB

626:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 18:27:20.59 JI8Cij+qM.net
‚»‚ë‚»‚ëƒs[ƒ^[‚àSP‚ð‘ˆõ‚·‚é•K—v‚ª‚ ‚é‚©‚à‚µ‚ê‚ñ‚È

627:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 18:36:02.42 VdFNzKm/0.net
>>537@>>540
‚±‚Ì•Ó‚ªƒtƒ‰ƒO‚É‚È‚Á‚Ă邶‚á‚Ë[‚©‚æ

628:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 18:38:12.05 rcWMFyqj0.net
>>593
’Ê•ñ‚µ‚Ü‚µ‚½I

629:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 18:38:15.36 CimXzdqLa.net
•’ÊAŽÐ’·‚¶‚á‚È‚­‚ĉº‚°‚Ä“¾‚µ‚Ä‚é‹@ŠÖ‚ɉ…‚Ýs‚­‚ÆŽv‚¤‚ñ‚¾‚ª

630:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 18:48:12.21 VJpuUSnId.net
‚»‚Ì‚¤‚¿‹@ŠÖ‚ÉŒ¾‚Á‚Ä‚ñ‚¾‚æƒoƒJƒ„ƒ[

631:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 18:48:41.11 OHn7nQO+0.net
¡“ú‚©‚çŽQ킵‚½1250‰~@1000Š”‚Ì‚í‚¢
‚‚Ý‚ÌŒ©•¨

632:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 18:55:03.14 UfT/QlAld.net
>>602
‰½ŒÌ”ƒ‚Á‚½c

633:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 19:07:16.22 mWZvwoInd.net
3Œ…ƒ^ƒbƒ`‚µ‚Ä—ˆ‚»‚¤‚¾‚ÈA‚¨‚¢‚¨‚¢

634:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 19:36:49.03 QwBDwAfq0.net
>>604
ƒTƒCƒo[ƒ_ƒCƒ“‚³‚ñ‚ª‘Ò‚Á‚Ä‚Ü‚·‚æ

635:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 19:37:40.90 JIZYOHHar.net
>>602
‚Ü‚½•ª‚‚¢Š‚ðEEE

636:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 19:39:48.32 EctzmkhhM.net
‚Æ‚è‚ ‚¦‚¸800‚܂ł͉º‚°‚é‚Å‚µ‚å

637:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 19:46:14.95 Ne5TXfvb0.net
V‹K’ñŒg‚É”º‚¤ˆêŽž‹à‚ÍŒ©ž‚Ý‚Ü‚¹‚ñi˜‚¦’u‚«j
ŒˆŽZ‘‚É‚±‚ñ‚È•¶–Ê‚ð‹LÚ‚·‚鎞“_‚ŃoƒCƒI‚ÌŒo‰cŽÒ‚Æ‚µ‚Ă̓IƒƒRƒ“‚¾‚ë
ŽèŽD‚ðŒ©‚¹‚ăgƒ‰ƒ“ƒv‚µ‚Ä‚ñ‚¾‚º
‚»‚è‚á‹ó”„‚èŠOŽ‘‚Í‹­‹C‚Å”„‚è‚Ü‚­‚邾‚ë
‘Ž‘‚Í‚µ‚Ü‚¹‚ñ‚©‚ç‚Ì‘Ž‘‚µ‚½ŒoˆÜ‚ª‚ ‚é‚©‚çAˆêŽž‹à‚ÍŒ©ž‚Ý‚Ü‚¹‚ñ‚©‚ç‚Ì‘åŒ^Œ_–ñ‚ðŽæ‚Á‚Ä‚±‚¢‚âƒ{ƒP
‹ó”„‚èŠOŽ‘‚ð‚Ô‚¿ŽE‚µ‚Ä“¥‚Ýã‚°‚È‚¢‚Æオ‚ç‚È‚¢‚í

638:ŽRŽt‚³‚ñ—ƒgƒŒ[ƒh’†
18/08/15 19:46:15.95 BJmL0BYIa.net
>>602
Œ»•¨‚È‚ç‘A‚Ü‚µ‚¢‚ÈB—ˆ”N•Ó‚è‚܂ʼn䖂©‚à‚¾‚ªB


ŽŸƒy[ƒW
ÅVƒŒƒX•\Ž¦
ƒXƒŒƒbƒh‚ÌŒŸõ
—ÞŽ—ƒXƒŒˆê——
˜b‘è‚̃jƒ…[ƒX
‚¨‚Ü‚©‚¹ƒŠƒXƒg
¥ƒIƒvƒVƒ‡ƒ“‚ð•\Ž¦
‰É‚‚Ԃµ2ch

1430“ú‘O‚ÉXV/273 KB
’S“–:undef